Author: PAVACA

BFA in Piano; BFA in Music Education; MA in Leadership. Retired professional musician and soprano, teacher, composer, accompanist/coach. General Editor of Imagination-Building: The Memoirs of John Douglas Forbes (1910 - 2018), First Professor of the Darden School of the University of Virginia. Writes under the names of: M.E. Forbes; M.E.C. Forbes; PAVACA.

Health Friday 4.24.2026 Open Thread: The COVID-19 Bioweapon “Vaccines”: Why Are They Still In Use?, Part One: Pfizer-BioNTech (COMIRNATY)

The vintage image of a vaccination record from 1867 for today’s offering header is courtesy of iStock and Google Images.

Health Friday is a series devoted to information about Big Pharma, vaccines, general health, and associated topics. There are Important Notifications from our host, Wolf Moon; theRules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: AI-generated items in today’s offering will be cited as such. If readers wish to post AI-generated content in today’s discussion thread, they must cite their source. Thank you.

Today’s offering begins here: https://icandecide.org/wp-content/uploads/2022/03/125742_S1_M2_26_pharmkin-tabulated-summary.pdf, “MODULE 2.6.5 PHARMACOKINETICS TABULATED SUMMARY“, FDA Approved on 21 January 2021 at 23:22 GMT (Greenwich Mean Time.) This is the report regarding biodistribution data of the Pfizer-BioNTech modRNA COVID-19 bioweapon “vaccine”, BNT162b2, for which the FDA had granted the initial EUA (Emergency Use Authorization) for use in the United States on 11 December 2020. The experiments performed by Pfizer-BioNTech to produce the report, using BNT162b2 injections, were conducted on Wistar Han lab rats, Sprague Dawley lab rats, Cynomologus monkeys, and human liver microsomes and liver fractions. Data were extracted from in vivo and from in vitro results. The formulation of BNT162b2 used in the experiments was the same as that which was granted the FDA Emergency Use Authorization of 11 December 2020 for use on human beings in the United States.

Yours Truly presents images of page 7 and page 8 of this report:

Note: the above data are the results from the injections given to the Wistar Han lab rats. Note also the accumulations of the lipid nanoparticles (LNPs), ALC-0159 and ALC-0315, used in the BNT162b2 formulation. Again, this is the same formulation that was granted the initial FDA Emergency Use Authorization on 11 December 2020, for BNT162b2 to be used on human beings in the United States. LNPs are the tiny fat molecules-based, lab-created “delivery system” that encases the “vaccine” ingredients to protect them from being detected and eliminated by the natural immune system of the body. Instead, the LNPs facilitate the entry of the “vaccine” into every cell of the body. Look at the highest accumulation amounts:

Adrenal Glands: 18.2. The adrenal glands release hormones, such as, adrenaline, directly into the bloodstream. These glands are crucial in the proper function of blood pressure and the body’s stress response. https://my.clevelandclinic.org/health/body/23005-adrenal-glands

Injection Site: 165. The injection of COMIRNATY into the arm of a human being results in the following: The body immediately sends “alarm signals” that there is an “enemy invader”, and starts the natural immune system process of fighting it / eliminating it. This is manifested in several ways, including: pain at the injection site, and/or a “rash” at the injection site. However, these immediate reactions can also indicate early-warning signals of anaphylactic shock — and must be closely monitored. Establishment Medicine explains this away by, first, stating that this reaction is “rare”, then proceeding to minimize the situation: https://ubiehealth.com/doctors-note/rash-after-covid-vaccine-causes-serious-warning-49121exp1, “Why do some people get a rash after the COVID vaccine and when is it serious?”, Yoshinori Abe, MD, 17 December 2025. This situation is called “COVID Arm.” In fact, Establishment Medicine minimizes “COVID Arm” reaction even if it occurs DAYS or a WEEK after “vaccination”: https://medlineplus.gov/ency/imagepages/19970.htm. “Arm Rash After COVID-19 Vaccination”, updated by Linda J. Vorvick MD, 1 January 2025.)

Liver: 24.3. This incredibly important organ performs five hundred different functions in the body to maintain health. https://www.michiganmedicine.org/health-lab/what-does-the-liver-do-and-how-do-i-keep-mine-healthy

Ovaries: 12.3. The female ovaries make and release eggs for fertilization. They also produce hormones. At birth, a female has all the eggs that she will ever have. The ovaries constantly “communicate” with the brain. https://axiawh.com/resources/5-things-you-didnt-know-about-your-ovaries/

Spleen: 23.4. The spleen creates white blood cells and stores red blood cells. It helps to regulate blood platelets (which assists in proper blood clotting.) It filters out old or damaged blood cells. https://www.healthline.com/health/what-does-the-spleen-do

The above report, in Yours Truly’s opinion, needs to be required reading for any healthcare professional who is still “recommending”, let alone administering, COMIRNATY. And, in case a healthcare professional raises objections, such as, “The new COMIRNATY formula is different”, the facts that ALC-0159, ALC-0315, N1-Methylpseudouridine (all which were in the original BNT162b2 formulation), and the S1 spike protein (that can be traced back to the original Wuhan Hu1 SARS-CoV-2 strain) are ingredients in the “2025-2026 COMIRMATY” version of the injectable.

There is a reason behind why the accumulations of ALC-0159 and ALC-0315 are so high for the above body areas and organs: these lipid nanoparticles ensure that the ingredients and mechanisms of COMIRNATY enter these areas and organs: with the result that said areas and organs are interfered with, and/or damaged, and/or that the body’s ability to properly use them is destroyed. Example: over 60% of the lifetime supply of a female lab rat’s eggs are either damaged or destroyed due to it being “vaccinated” with COMIRNATY: https://www.thefocalpoints.com/p/breaking-covid-19-mrna-shots-destroy, “BREAKING: COVID-19 mRNA Shots Destroy Over 60% of Female Non-Renewable Egg Supply”, Nicolas Hulscher, 9 May 2025. If this is what happens with female Wistar lab rats being injected with these “vaccines”, the potential for damage to human female eggs is ALSO THERE: and, in fact, the Manniche, et al., study demonstrates this: https://www.preprints.org/manuscript/202504.2487/v1, “Rates of Successful Conceptions According to COVID-19 Vaccination Status: Data from the Czech Republic”, Vibeke Manniche, et al., 29 April 2025. Note: this paper is a preprint — therefore, it can be Removed, Retracted, or Withdrawn at any time. Yours Truly urges interested readers to download or otherwise archive this paper.

Before leaving the discussion of ALC-0159 and ALC-0315, please see the following images from the MSDS Safety Sheets for these lipid nanoparticles, below. First, from https://cdn.caymanchemical.com/cdn/msds/34336m.pdf, for ALC-0159:

And, from https://cdn.caymanchemical.com/cdn/msds/34337m.pdf, for ALC-0315:

Note that both compounds are for research only. In fact, both compounds rate as a carcinogen (ethanol content.) In particular, the Cayman Chemcial MSDS for ALC-0315 reads like a textbook example of a very dangerous compound.

**** Note from the images of Page 7 and Page 8 above, that BNT162b2 crosses the Blood-Brain Barrier, as seen in the accumulation data images above: the “vaccine” accumulates in the Brain and in the Pituitary Gland. In addition, there is BNT162b2 accumulation in the Skin and in the Kidneys — this indicates that the “vaccine” ingredients can be “shed” from the skin and/or excreted via the kidneys into urine.

The Appendix 1: List of Adverse Events of Special Interest section of this report about BNT162b2, also given to the FDA by Pfizer-BioNTech (April 2021) has the reports listings of over 1,200 serious / fatal side effects induced by this “vaccine.” The report is found here: https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf, “5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021“, FDA date-stamped 30 April 2021 at 09:26 GMT. This, in Yours Truly’s opinion, also needs to be required reading for any healthcare professional who is still “recommending”, let alone administering, COMIRNATY.

The COVID-19 bioweapon “vaccines” are actually gene-altering injectable therapies: they are not, strictly speaking, vaccines. Please see: https://academic,oup.com/intimm/article/33/10/521/6194108, “Development of COVID-19 vaccines utilizing gene therapy technology”, Hironori Nakagami, 27 March 2021. Every single person who has ever taken an injection of COMIRNATY has had a gene-altering therapy “cocktail” (under the guise of “it’s a vaccine”) injected into their body: something that “vaccinated” persons were never told about, nor for which they never explicitly granted permission to have put into their body.

>>>>>>>>>>>>>>>>>>>>>>>>

HHS Secretary Robert F. Kennedy, Jr., is not being allowed to do his job — and, in fact, to quote another blog writer, he is being “muzzled.” The COVID-19 bioweapon “vaccines” have been, via the American Academy of Pediatrics lawsuit and subsequent “ruling” by Federal Judge Brian E. Murphy, are now fully back into the CDC Childhood Immunization Schedule. The new nominee to head the CDC, Dr. Erica Schwartz, is an Establishment Medicine “vaccine” proponent: https://aaronsiri.substack.com/p/the-queen-of-mandating-vaccines, 18 April 2026. A screenshot from this article is below:

Please also see: https://www.2ndsmartestguyintheworld.com/p/iatrocide-by-design-rfk-jr-bombshell, “Iatrocide by Design: RFK Jr. Bombshell: “They had to DESTROY Ivermectin and Hydroxychoroquine…” “, 23 April 2026. A screenshot from the latter article is below:

The linked tweet from the above article:

>>>>>>>>>>>>>>>>>>>>>>>>

THERE IS NO PLACE IN THE HUMAN BODY FOR AN mRNA, A modRNA, AN saRNA, OR A taRNA PRODUCT OF ANY KIND.

THERE MUST BE MUCH MORE RESEARCH INTO THESE DELIVERY PLATFORMS, WITH EXTENSIVE TESTING AND DATA ANALYSES, AND WITH THE RESULTS BEING MADE PUBLIC.

THE COVID-19 BIOWEAPON “VACCINES” (GENE-THERAPY INJECTIONS) — ALL OF THEM — MUST BE REMOVED FROM THE MARKET AND FROM USE IN THE UNITED STATES. NOW.

Peace, Good Energy, Respect: PAVACA

(Intellectual Property Disclaimer and Notice: Except for URLs and other items that are available on the Internet, the ideas and/or opinions in today’s offering are by PAVACA. Proper credit must be given to PAVACA for ideas and/or opinions in today’s offering are used by other blog writers, by podcasters, or in print or social media.)

Health Friday 4.17.2026 Open Thread: The Sleight-of-Hand at HHS Must Stop. Now.

The vintage image of mass vaccination for today’s offering is courtesy of Google Images.

Health Friday is a series on information regarding Big Pharma, vaccines, general health, and associated topics. There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: AI-generated items in today’s offering, if any, will be cited as such. If readers wish to post AI-generated items in today’s discussion thread, they must cite their source. Thank you.

The United States Department of Health and Human Services (HHS) is still funding Gain-of-Function research. This is despite the 5 May 2025 directive from the White House regarding pausing all Gain-of-Function research by HHS (https://www.whitehouse.gov/presidential-actions/2025/05/improving-the-safety-and-security-of-biological-research/.) Examples: Arcturus Therapeutics is still under a “Fast Track” status granted to the company in April 2025 by the FDA — a Fast Track status granted for the development and testing of the company’s self-amplifying RNA (saRNA) “influenza vaccine”, ARCT-2304 (also known as, LUNAR-FLU or as LUNAR-H5N1 (https://ir.acrturus.com/news-releases/news-release-details/acturus-therapeutics-receives-us-fda-fast-track-designation-0, 10 April 2025.)

Yours Truly begins here: https://jonfleetwood.substack.com/p/hhs-funds-gain-of-function-influenzacovid, “HHS Funds Gain-of-Function Influenza — COVID ‘Frankenvirus’ Combining Influenza Entry With SARS-CoV-2 Human Cell – Binding Domain”, 10 April 2026. Two screenshots regarding this are below: the first, from the Fleetwood article; the second, from the paper itself (published December 2025). Thanks to Mr. Fleetwood for this information:

By the way, NIH grant P01-AI165075 (going to Rockefeller University, New York) has multiple “permutations” in the https://reporter.nih.gov/ listing. **** The “permutation” that helped to fund the paper below (cited in the Fleetwood article) is 3P01AI165075 – 01S1, Sub-Project ID: 6568, awarding entity NIAID, total funding: $983,100. (And this is only ONE “permutation” of P01-AI165075.)

**** What this lab-created “combo virus”, called X31 H3 S-RBD in the paper, contains:

The RBD (Receptor Binding Domain) from the Wuhan Hu1 SARS-CoV-2 virus (the original COVID-19 virus); plus

Seven other viral RNAs (vRNAs) from the H1N1 (Influenza A) Puerto Rico/1/1934 strain (PR8)

The Abstract of this paper is below. It is a clear statement that Gain-of-Function was used to lab-create this “combo virus” (lines 28 – 35):

Let’s take a look at the involvement with the Chinese Academy of Medical Sciences (CAMS) in the study that produced this paper. The paper states that Tiong Kit Tan, of the Chinese Academy of Sciences – Oxford Institute, Nuffield Department of Medicine, University of Oxford, is one of the researchers/co-authors. CAMS is a collaborator with the Chinese Communist People’s Liberation Army (PLA.) CAMS is one of the “Top 5” domestic (Chinese-based) collaborators with the PLA. Please see: https://www.nature.com/nature-index/institution-outputs/china/people-s-liberation-army-pla/555c2052140ba014648b456b; scroll down the page to the list of “Domestic Collaborators.”

Further down the page, there is the list of “International Collaborators” with the PLA. It is interesting to note that NUS (National University of Singapore) is ranked as Number One here. It is also interesting to note that NUS has a large medical school that is a “satellite” of Duke University (Chapel Hill, North Carolina; https://www.duke-nus.edu.sg.)

CAMS also has ties to Yale University via the CMB Foundation Global Health Research Fellowship in Communist China (https://medicine.yale.edu/education/othereducation/cmb/foundation-global-health-research-fellowship-in-china/cams-pumc/; PUMC is Peking Union Medical College); to Harvard Medical School; and, to the NIH (https://www.science.org/cms/asset/ecaa3321-8b14-45e9-b549-1631422a83ea/cams_booklet_2016_11_18.pdf, pages 44-45.)

The question arises: How much research data, analyses, lab samples, and more, from these “international collaborators” with the Chinese Academy of Medical Sciences, wind up in laboratories run by the People’s Liberation Army in hospitals and universities throughout Communist China?

>>>>>>>>>>>>>>>>>>>>

Let’s look at a recent example of “Gain-of-Function Experiments Gone Wrong”: https://childrenshealthdefense.org/defender/exclusive-bird-flu-outbreak-40-miles-wisconsin-lab-sparks-concern-gain-of-function-experiments/, “Exclusive: Bird Flu Outbreak 40 Miles From Wisconsin Lab Sparks Concern About Gain-of-Function Experiments”, Michael Devradakis, PhD, 15 January 2026. A screenshot from this article is below:

Yoshihiro Kawaoka, DVM, PhD, is also the scientist who is heavily involved with Gain-of-Function experiments at the University of Wisconsin-Madison. And, that there is a record of prior accidents and leaks from his lab there: https://www.cidrap.umn.edu/biosecurity-issues/wisconsin-lab-broke-ebola-rules-watchdog-group-says, 25 September 2007; and, https://www.wispolitics.com/2023/wisconsin-congressional-republicans-demand-answers-on-biosafety-incident-at-uw-madison/, 23 April 2023.

The NIH grant that helped to fund Dr. Kawaoka’s work for the above cited paper is 75N93021C00014. The grant contract information is found here: https://www.highergov.com/contract/759321C00014/. An image of the Government Description of this grant, from the website, is below:

Note that sentence about, “Includes international and domestic basic and clinical influenza research…” — in other words, covering “collaborators” like CAMS. Note that “studies of viral evolution, transmission, and immune responses in animal models and humans” covers Gain-of-Function work.

CEIRR stands for Centers of Excellence for Influenza Research and Response. The website description of this research division of NIAID is here: https://www.niaid.nih.gov/research/centers-excellence-influenza-research-response. Scroll down the page to “Main Areas of Focus” to this statement: “To support projects to determine how influenza viruses evolve, adapt and transmit between humans and at interspecies interfaces”. This is “code” for supporting Gain-of-Function research on influenza viruses. There are multiple “permutations” of NIH grant 75N93021C00014 listed at https://reporter.nih.gov/search/6vlkhZH5302zeKPiGnsO5g/projects, most of which were awarded to the Icahn School of Medicine at Mount Sinai, New York (one of the CEIRR main hubs of research.)

>>>>>>>>>>>>>>>>>>>>

Yours Truly turns to what might be, in her opinion, called a “permutation” of Gain-of-Function research: experiments on human beings to further a Patent invention.

The Patent in question is: US11369675B2, “Broadly protective inactivated influenza virus vaccine”, held by Dr. Jeffery Taubenberger, MD, Acting Director of NIAID. The Patent declaration is found here: https://patents.google.com/patent/US11369675B2/en. The application for the Patent was filed on 12 October 2020; the Patent was granted on 28 June 2022; the “Adjusted expiration” date of the Patent is 24 January 2039; and, the Patent was assigned to the Department of Health and Human Services (HHS.) Dr. Taubenberger, during this timeline, was an employee of HHS, before he became Acting Director of NIAID. He, in fact, is a career HHS (NIH) employee.

Dr. Taubenberger’s Patent describes a “universal influenza vaccine.” Yours Truly has written on this situation; for example: https://www.theqtree.com/2025/05/16/health-friday-open-thread-5-16-2025-about-that-universal-vaccine-theres-more-than-meets-the-eye-part-two/.

It appears that Dr. Taubenberger is working to further the Patent regarding the development of an intranasal “universal influenza vaccine.” His most recent published paper in this regard is here: https://pmc.ncbi.nlm.nih.gov/articles/PMC12375958/S#23, “Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunity”, Jeffery Taubenberger, et al., 6 August 2025. This paper describes a very small study of 74 persons (originally 80 persons) that was conducted in 2019 per the cited paper above (NCT01971255.) However, the ACTUAL study dates of NCT01971255, per https://clinicaltrials.gov/study/NCT01971255, indicate a timeframe between September 2013 and September 2015. In addition, the referenced paper number 11 in the cited paper above describes the same experimental study, but via a paper published about it in 2024 (https://pmc.ncbi.nlm.nih.gov/article/PMC10865821/, “Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers”, Jeffery Taubenberger, et al., 9 January 2024.) This, to Yours Truly, raises questions regarding the timing of the publishing of these papers, since the actual study was conducted over 10 years ago. What goes on here?

The bottom lines of NCT10971255: there were 80 enrolled study subjects; half were vaccinated with a licensed influenza “vaccine”; half were unvaccinated; ALL subjects were then given an intranasal LIVE VIRUS H1N1 (swine flu), called Ca/04/2009/H1N1r Challenge Virus; ALL subjects were then tested numerous times via a middle turbinate nasal swab (this means that the swab samples were taken from well inside the upper nasal cavity each time); apparently, ALL subjects became ill with flu symptoms, some of which were severe; 6 study subjects withdrew for various reasons; all testing using the “intranasal challenge virus” was performed at the NIH Clinical Center in Bethesda, Maryland; the study subjects were brought there for the “challenge” (and likely had to stay there or in the immediate area, as they were assessed daily for a minimum of 9 days.)

Yours Truly will point out that Patent holders at HHS (NIH; NIAID) can earn significant royalty payments for the use of the their registered inventions. Please see: https://www.lankford.senate.gov/news/press-releases/lankford-hsgac/republicans-request-information-from-nih-on-the-disclosure-of-royalty-payments-to-nih-employees/, 1 June 2022.

Dr. Taubenberger is the recipient of NIAID research funding related to Avian Influenza viruses, his “universal influenza vaccine”, and to the SARS-CoV-2 virus — in the 2025 fiscal year, among other years. However, 2025 is the year in which Dr. Taubenberger became the Acting Director of NIAID. The “umbrella grant” prefix number is either 1ZIAAI00 or 1ZIAAI000, each followed with the suffix number: for example, 1ZIAAI001372-03, “Universal Influenza Vaccine Development”, for $2,153,677. This grant, as at least one other per https://reporter.nih.gov/ (search: Jeffery Taubenberger), lists NO contact data; NO Project Start Date; NO DUNS number; NO Budget End Date; among other lack of public information. What goes on here? Is Dr. Taubenberger perhaps granting NIAID research funds to himself?

>>>>>>>>>>>>>>>>>>>>

Finally, is appears that HHS Sec. Robert F. Kennedy, Jr., is going to start a podcast:

Sec. Kennedy, Jr., states that he will “…ask the questions and lift the taboos and expose the hypocrisy and the conflicts and the corruption…We’re going to follow the evidence wherever it leads, and we’re going to name the names of the forces that obstruct the paths to public health.”

All well and good. However — will Sec. Kennedy, Jr., “name the names”, such as: the person who invented the SARS-CoV-2 virus itself — Dr. Ralph Baric of the University of North Carolina, Chapel Hill? Such as, the person who could have stopped the entire COVID-19 “vaccine” disaster in the United States in December 2020, but who instead signed off on the CDC’s “recommendation” for the use of Pfizer-BioNTech’s modRNA COVID-19 bioweapon “vaccine”, BNT162b2, without any further investigation — Dr. Robert Redfield, then-Director of the CDC? Such as, the person who was responsible for the NIAID funding that produced the SARS-CoV-2 virus itself — Dr. Anthony Fauci, former NIAID Director? Such as, the USAMRIID personnel responsible for working with PfizerUSA (Pfizer-BioNTech) in the development of BNT162b2? Will Sec. Kennedy, Jr., “name the names” of the products that, by far, have obstructed, and continue to obstruct, “the paths to public health” — the COVID-19 bioweapon “vaccines”?

ALL GAIN-OF-FUNCTION WORK IN THE UNITED STATES, OF ANY TYPE, MUST BE STOPPED. NOW.

Peace, Good Energy, Respect: PAVACA

(Intellectual Property Disclosure and Notice: Except for the linked URLs and other items that can be found in the Internet, the ideas and/or opinions of today’s offering are by PAVACA. Credit must be given to PAVACA if the ideas and/or opinions of today’s offering are used by other blog writers, podcasters, or in social or print media.)

Health Friday 4.10.2026 Open Thread: Some Interesting Links

The header image of the word Interesting for today’s offering is courtesy of Shutterstock and Google Images.

Health Friday is a series devoted to information regarding Big Pharma, vaccines, general health, and associated topics. There are Important Notifications form our host, Wolf Moon; the Rules of our late, good Wheatie; and certain caveats from Yours Truly, of which the reader should be aware. They are linked here. Note: AI-generated items in today’s offering are cited as such. if readers wish to post AI-generated items to today’s discussion thread, they must cite their source. Thank you.

Some Interesting Links:

Regarding the November 2025 exposure of an employee at the Rocky Mountain Lab (part of the NIH) to the Crimean-Congo Hemorrhagic Fever virus. The virus is being experimented on at this facility. Our good Aubergine posted a comment on this situation, which began a discussion: https://theqtree.com/2026/04/03/health-friday-4-3-2026-open-thread-where-the-focus-needs-to-be-now-an-opinion-piece/#comment-1595800. It has been proven that this virus does indeed shed; the shedding can be present in the body secretions and blood of the exposed / infected person. The published paper regarding shedding of Crimean-Congo Hemorrhagic Fever virus is here: https://pmc.ncbi.nlm.nih.gov/articles/PMC7078823/, “Monitoring Crimean-Congo haemorrhagic fever virus RNA shedding in a body secretions and serological status in hospitalized patients, Turkey, 2015.” Dilek Yagci-Caglayik, et al. 12 March 2020. (Yours Truly: While the paper is about the shedding of this virus in hospitalized patients, it, in my opinion, opens up the possibility that the virus can shed from non-hospitalized exposed or infected persons.)

>>>>>>>>>>>>>>>>>>>>>>>>

In Maryland, if a newly-proposed law there comes into effect, pharmacists will be able to order certain “vaccines” for patients; while, at the same time, placing the names of those persons into the Maryland state database for immunization tracking: https://jonfleetwood.substack.com/p/maryland-bill-lets-pharmacists-order, “Maryland Bill Lets Pharmacists Order Vaccines for You — Logging Your Name in State Tracking System Without Any Patient-Request Requirement”, 3 April 2026. A screenshot from this article is below:

Note that this bill regards pharmacists being granted permission to order vaccines — and to do so without the patient’s knowledge, consent, or request. The name of the patient is put into a state tracking database. The vaccines are paid for by private insurance (if the patient’s private insurance information is on file at the pharmacy), or are covered by Medicare/Medicaid. This opens up the potential for both the pharmacy and the state to “keep tabs” on the patient in order to get “vaccine compliance” from the patient.

>>>>>>>>>>>>>>>>>>>>>>>>

Why hasn’t James Lloyd Austin, III, Secretary of Defense under former “President” Joe Biden, been held to account for his “mandating” over 90% of United States military personnel being “vaccinated” with modRNA COVID-19 bioweapon “vaccines”? https://www.thefocalpoints.com/p/breaking-study-half-of-covid-19-vaccinated, “BREAKING STUDY: Half of COVID-19 Vaccinated Military Personnel Suffered Subclinical Heart Stress”, Nicolas Hulscher, MPH, 31 March 2026. The paper cited in the article is here: https://doi.org/10.1016/j.vaccine.2026.128535, “Transient elevation of NT-proBNP after mRNA COVID-19 vaccinations in healthy adults: A longitudinal biomarker analysis.” Pavel Dlouhy, et al. 30 April 2026.

Note that this paper studies heart issues that appeared in 50% of 83 healthy, adult military personnel after their being “vaccinated” with either BNT162b2 (Pfizer-BioNTech) or with mRNA-1273 (Moderna.) The military personnel were stationed at the Air Transportation Base Facility in Prague, Czech Republic. The troponin levels of their hearts were found to have gone up. Elevated troponin levels in the heart indicate stress on the heart muscle. Elevated troponin levels can indicate heart problems even if there are no overt symptoms. If that is what occurred in half of the “vaccinated” personnel tested at an air transportation base in the Czech Republic, how many thousands of United States military personnel potentially had the same effect after they were “mandated” to be “vaccinated” by former Defense Secretary Austin? (Austin was the former Secretary of what is now called the Department of War.)

Note also that the military personnel at the air transportation base in Prague were well over the age of 17 — in fact, the mean age of the 83 tested personnel was 39 years. This blows clean out of the water ALL of the claims of Big Pharma, Establishment Medicine, the CDC, the FDA, the AMA, and many other entities, that heart problems associated with COVID-19 “vaccination” are “rare” —and, are “confined mostly to persons between the age of 12 and 17 years.”

>>>>>>>>>>>>>>>>>>>>>>>>

Another example of how a physician who stood up against Big Pharma, the CDC / FDA, the AMA, and the AAP (American Academy of Pediatrics), was persecuted: his License to Practice Medicine in his home state (Oregon) was suspended in 2020; then, his License to Practice Medicine was revoked in the state where he had been credentialed (Washington State); then, his board credentials in the AAP were revoked; then, he had to surrender his License to Practice Medicine in Oregon in 2022 (https://omb.oregon.gov/Clients/ORMB/Public/VerificationDetails.aspx, effective 5 December 2022.) This was the journey of Dr. Paul Thomas, a highly-respected pediatrician: https://www.2ndsmartestguyintheworld.com/p/doctor-published-study-showing-vaccinated, “Doctor Published Study Showing Vaccinated Children Have 500% Increase In Chronic Diseases Only To Have License Suspended & Get Cancelled By BigPharma”, 8 April 2026. The study was Retracted by MDPI, the preprint publisher. It is available here: https://www.researchgate.net/publications/346088816_Relative_Incidence_of_Office_Visits_and_Cuulative_Rates_of_Billed_Diagnoses_Along_the_Axis_of_Vaccination. James Lyons-Weiler, Paul Thomas. 22 November 2020. (Yours Truly: Note that this paper was accepted and peer-reviewed before it was published.)

>>>>>>>>>>>>>>>>>>>>>>>>

Dr. Peter A. McCullough addresses the nexus among cancer patients who then get COVID-19 “vaccinated” and thereupon afterwards present with symptoms of Long COVID: https://www.thefocalpoints.com/p/the-hollow-promise-of-protection, 7 April 2026. A screenshot from this article is below (access to the entire particle is for subscribers only):

The paper cited in the above article is here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2847136. “Postacute Sequelae Following Omicron COVID-19 in Patients With Cancer.” Ling En Wee, MPH, et al. 31 March 2026.

>>>>>>>>>>>>>>>>>>>>>>>>

A related topic to the heart issues situation found in the military personnel at the air transportation base in Prague who had been COVID-19 “vaccinated”: This one regards subclinical myocarditis/pericarditis in COVID-19 “vaccinated” persons: https://www.thefocalpoints.com/p/breaking-peer-reviewed-paper-finds, “BREAKING: Peer-Reviewed Paper Finds mRNA “Vaccines” Convey Silent Heart Damage—Presents Approach to Diagnosis and Management”, Nicolas Hulscher, MPH, 31 December 2025. A screenshot from this paper is below:

The paper is found here: https://doi.org/10.1810/mra.v13i11.7078, “COVID-19 Vaccine-Induced Subclinical Myopericarditis: Pathophysiology, Diagnosis, and Clinical Management.” Peter A. McCullough, MD, MPH, M. Nathaniel Mead, MSc, PhD, Nicolas Hulscher, MPH. 30 November 2025.

Yours Truly: The above paper speaks to subclinical myocarditis/pericarditis in COVID-19 “vaccinated” persons — and makes it clear that, although many of the reported cases were found in “vaccinated” males under age 21, there were cases found in other “vaccinated” persons (male and female), and in other age groups. On the other hand, there is also the real phenomenon of “vaccine” shedding from “vaccinated” persons onto others, including onto non-COVID-19 “vaccinated” persons. Who knows how many non-COVID-19 “vaccinated” persons (including children) have been exposed to the ingredients and mechanisms of these “vaccines” that induce heart problems? At the same time, there are other factors that need to be considered when talking about what engenders or aggravates heart issues. Examples of other factors can include, but are not limited to: chronic stress; hypertension; family history of / predisposition to, heart disease; and, COPD (https://www.ummhealth.org/health-library/copd-and-heart-disease.)

THERE IS NO PLACE IN THE HUMAN BODY FOR AN mRNA, A modRNA, AN saRNA, OR A taRNA PRODUCT OF ANY KIND, IN ANY FORM.

ALL GAIN-OF-FUNCTION ACTIVITIES IN THE UNITED STATES MUST BE STOPPED, NOW.

ALL COVID-19 BIOWEAPON “VACCINES” MUST BE PULLED OFF THE MARKET AND REMOVED FROM USE IN THE UNITED STATES, NOW.

Peace, Good Energy, Respect: PAVACA

Health Friday 4.3.2026 Open Thread: Where the Focus Needs to Be Now: An Opinion Piece

The header image of FOCUS used for today’s offering is courtesy of Rio Salado College and Google Images.

Health Friday is a series devoted to information about Big Pharma, vaccines. general health, and associated topics. There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: AI-generated items in today’s offering will be cited as such. If readers wish to post AI-generated items in today’s discussion thread, they must cite their source. Thank you.

To those who commemorate Passover; or, Holy Week, Good Friday and Easter Sunday: May the blessings of these observances be granted to you.

Yours Truly has posted dozens of articles on this board related to the COVID-19 bioweapon virus itself; and, to the COVID-19 bioweapon POISON “vaccines.” These articles have traced the origins of the virus itself; the development of the “vaccines”; the gaslighting and psyops techniques that have been used (and, are still being used) to frighten / suborn / coerce / “mandate”, billions of human beings into having these “vaccines” put into their body; the myriad of “vaccine”-induced or “vaccine”-aggravated illnesses, injuries, and disabilities that are presenting in “vaccinated” persons; the deaths caused by these “vaccines”; and more. https://www.theqtree.com/author/pavaca/.

To date, those who lab-created the COVID-19 virus itself; who lab-created the COVID-19 “vaccines”; who deliberately withheld important information about the virus itself, and about the “vaccines”, from then-President Donald Trump 45; who used the government (on all levels) to lock down millions of Americans for months to “stop the spread”, and to enforce “vaccination” on millions of Americans; who still inject thousands of Americans every day with these bioweapon POISON “vaccines” — have not been held to account. They have not been held account when they lied in sworn testimony before Congress (as did Dr. Anthony Fauci, when he stated in congressional testimony that he never knew or met Dr. Ralph Baric.) Please see: https://usrtk.org/covid-19-origins/fauci-discussed-gain-of-function-work-with-wuhan-collaborator-in-pandemics-earliest-days-emails-suggest/, by Emily Kopp, 21 February 2023.

It appears that the Department of Health and Human Services, along with its CDC and FDA divisions, are in the control of Big Pharma, Establishment Medicine organizations, and the Federal Judiciary. It appears that HHS Secretary Robert F. Kennedy, Jr., is focused on “side bar” issues, such as revamping the “official government food pyramid chart”, and removing artificial colorings from foods, among other items. While these are good and worthy efforts in and of themselves, they detract from the absolute importance of immediately stopping all COVID-19 bioweapon “vaccines” use in the United States, and taking these “vaccines” off the market. The damage, illnesses, injuries, and deaths induced by these products are increasing; dozens of peer-reviewed scientific papers have proven that these serious and deadly effects, induced by these products, are real. Disability claims have been skyrocketing since the rollout of these products in 2021 — please see the charts compiled by Ed Dowd at https://phinancetechnologies.com/.

It appears that there is a “latest new variant” of the COVID-19 bioweapon virus itself, called BA.3.2, nicknamed “Cicada“, after the insect that stays underground for years before hatching and emerging into the atmosphere. This variant is a mutation of the earlier B.3 mutant of the SARS-CoV-2 bioweapon virus that “went out of circulation” in early 2022. However, it then “re-appeared” as BA.3.2 in a sample taken from a patient in South Africa in November 2024: https://www.cdc.gov/mmwr/volumes/75/wr/mm7510a1.htm, “Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2”, 19 March 2026. The BA.3.2 variant has now spread to multiple countries, including to the United States; it was found in wastewater samples from 25 states: https://news.northeastern.edu/2026/03/27/new-covid-19-cicada-variant/, “What you should know about the new COVID-19 ‘Cicada’ Variant”, Tanner Stening, 27 March 2026. A screenshot from the Stening article is below:

And, as if dutifully, the “mainstream media” is running with the “it’s a new variant outbreak” aspect: https://www.newsweek.com/map-shows-new-covid-variant-ba-3-2-spread-across-us-11745474, Giulia Carbonaro, 27 March 2026. A screenshot of the “outbreak map” in the article, courtesy of the CDC, is below:

Per Wikipedia (https://en.wikipedia.org/wiki/BA.3.2), the general summary list of SARS-CoV-2 virus variants:

Note where BA.3.2 is on this list. It is “descended” from a BA.3 Omicron variant (BA.1.1.529.3.) This places BA.3.2 (the “Cicada” variant that is the “new, latest variant”) closer up the list to the original Omicron variant (B.1.1.529) — hence, the “Cicada” nickname. Like the insect that hatches years after its eggs have been in the soil.

Note also the combination of both the BA.2 AND the BA.3 variants in BA.3.2. Both the BA.2 and the BA.3 variant lines are “heavily mutated.” And, in fact, the BA.3.2. “new, latest variant” has 70 to 75 mutations within it (per the Stening article, above.) In addition, per the CDC’s testing of samples of BA.3.2, this “new, latest variant” evades antibodies. The Scientific American article on BA.3.2, which mentions this, is here: https://www.scientificamerican.com/article/new-cicada-covid-variant-is-spreading-in-the-u-s-heres-what-to-know/, Tanya Lewis, 30 March 2026. A screenshot from this article is below:

It appears that both the BA.3 and the BA.3.2 SARS-CoV-2 virus variants were first detected in South Africa (regarding the emergence of BA.3: https://en.wikipedia.org/wiki/SARS-CoV-2_Omicron_variant#BA.3.) Let’s examine this situation.

First: GAVI (Global Alliance for Vaccines and Immunization, https://www.gavi.org/, was founded in Davos, and is funded by the Gates Foundation, among other entities / persons.) In 2021, GAVI announced an “investment opportunity” regarding launching a COVID-19 bioweapon “vaccine” program in South Africa: https://https://www.gavi.org/news/media-room/united-states-host-launch-event-gavi-covax-amc-2021-investment-opportunity. A screenshot from this press release is below:

The United States Secretary of State in April 2021 was Antony Blinken. The USAID Administrator in April 2021 was Gloria Steele (Acting Administrator; Samantha Power was sworn in as the Administrator on 3 May 2021.)

GAVI, the Gates Foundation, and COVAX went right to work on getting South Africa COVID-19 “vaccinated.” Per the Wikipedia entry regarding this situation (https://en.wikipedia.org/wiki/COVID-19_vaccination_in_South_Africa), the “vaccine” distribution pie chart, as of 2021:

The COVAX program in South Africa was ended on 31 December 2023: https://www.unicef.org/supply/covax-ensuring-global-equitable-access-covid-19-vaccines. COVAX was a coalition involving GAVI, WHO, and CEPI. CEPI (Coalition for Pandemic Preparedness Innovations, https://cepi.net/.) Among the funders of (investors in) CEPI are the Bill and Melinda Gates Foundation and the World Economic Forum (https://cepi.net/investors.) Below is a screenshot from the UNICEF article:

Does the reader see how the game is played? GAVI organizes an “investment opportunity” virtual meeting regarding funding for COVID-19 bioweapon “vaccine” programs in Africa, including in South Africa. The United States is heavily involved, via the Secretary of State and the USAID Administrator. Further involvement is orchestrated by GAVI to include UNICEF, CEPI, WHO, and (by extension) the WEF. Massive amounts of the COVID-19 modRNA bioweapon “vaccine” BNT162b2 are furnished by Pfizer-BioNTech for the “vaccination” program. Almost 80% of the eligible population in South Africa is “vaccinated” with BNT162b2, starting in early summer 2021. The BA.3 variant of SARS-CoV-2 emerges in South Africa, then it “doesn’t take off” and disappears — until it “re-emerges” (like the cicadas after years of dormancy) as BA.3.2 in November 2024 — in South Africa, from whence it is now detected in at least 23 countries, including in the United States. The CDC begins to “raise alarm” over this situation, especially since BA.3.2 has an “uncanny ability” to evade the antibodies supposedly “created” via the current COVID-19 modRNA bioweapon “vaccines”, or via prior COVID-19 infection and recovery.

Do not forget that the modRNA COVID-19 bioweapon “vaccines” do the following: One, to “trick” the “vaccinated” person’s body into thinking it is infected with the SARS-CoV-2 virus; which then forces the body to produce large amounts of immune system cells to “fight off” the “fake infection”, and which “vaccines” are at work in the body for at least 700 days post-injection (per the Yale LISTEN study); and, Two, to destroy the crucial RNA of the body’s natural Uridine, which under normal circumstances, would “alert” the body that there is an “enemy” (infection.) The RNA destruction is done by the N1-Methylpseudouridine in these “vaccines.” One of the principal scientific researchers who worked on One and Two above is Dr. Drew Weissman. Please see: https://www.brandeis.edu/now/2020/september/weissman-vaccine-mrna.html, Lawrence Goodman, 29 September 2020; and, https://www.brandeis.edu/magazine/2024/winter/the-brief/weissman-nobel.html. Two screenshots from these articles are below: the first, from the 2020 article; the second, from the 2024 article. Dr. Weissman, along with Dr. Katalin Kariko, received the Nobel Prize for their work with mRNA “vaccine” development:

Which illuminates the “why” behind the emergence of the BA.3 and the BA.3.2 variants in South Africa after the COVID-19 “vaccination” programs began in 2021; which illuminates the “why” behind the emergence of all the other SARS-CoV-2 variants; which illuminates the “why” behind the “breakthrough infections” and the “becoming infected with COVID despite being vaccinated” incidences since the rollout of these “vaccines” in December 2020; which illuminates the “why” behind the steady damage to / destruction of, the immune system of the “vaccinated” body.

And where is the “new ACIP roster” which was stated was coming, after Federal Judge Brian E. Murphy disbanded the group and reinstated the former CDC Childhood Immunization Schedule in his “ruling” of 16 March 2025? NOWHERE. There IS NO “new ACIP members roster.” There IS NO announcement of a meeting scheduled by this group.

What does this mean regarding the concept of FOCUS?

It means: Focus on the truth that the CDC (and, by extension, HHS and the FDA) are now controlled by outside interests: https://www.theqtree.com/2026/03/27/health-friday-3-27-2026-open-thread-hhs-is-controlled-by-big-pharma-the-american-academy-of-pediatrics-and-the-federal-judiciary/.

It means: Focus on the truth that HHS Secretary Robert F. Kennedy, Jr., is effectively negated in his ability to direct the department (and, by extension, the CDC and the FDA) — in other words, to do his job.

It means: Focus on the fact that it is “open season” on the people of the United States — from BEFORE birth and up until death — to be “vaccinated” with products that do NOT prevent disease; that do NOT prevent hospitalization from disease; that INDUCE a myriad of negative side effects, including death; that AGGRAVATE or RE-ESTABLISH pre-existing medical conditions that were under control / in remission, including cancer; to be injected with products that are NOT fully tested, the data NOT fully analyzed, and instead to be used as “human lab rats” for the Big Pharma companies that lab-develop / lab-create these products.

**** It means: Focus on the fact that people MUST do their own research — MUST do their own thinking — MUST make their OWN decisions, related to taking ANY “vaccine.” To allowing ANY “vaccine” to be put into their children. To question ANY healthcare provider who “recommends” ANY “vaccine.” To DEMAND to see the Package Insert for ANY “vaccine” that is “recommended” and to READ IT. To REFUSE ANY “vaccine” that raises ANY questions regarding “safety and efficacy” in the mind of the patient / parent(s) / guardian. To READ the reports in VAERS related to COVID-19 bioweapon “vaccine” serious adverse reactions / serious events. To stop blindly rolling up the sleeve for a “vaccine” injection because “Follow the science.”

THERE IS NO PLACE IN THE HUMAN BODY FOR AN mRNA, A modRNA, AN saRNA, OR A taRNA PRODUCT OF ANY KIND, IN ANY FORM.

THERE MUST BE, FIRST, MUCH MORE RESEARCH INTO THESE PLATFORMS, WITH COMPLETE AND PROPER TESTING, DATA ANALYSES, AND SAFETY AND EFFICACY REPORTING.

THERE MUST BE, SECOND, A TOTAL STOP TO ALL GAIN-OF-FUNCTION RESEARCH IN THE UNITED STATES.

Peace, Good Energy, Respect: PAVACA

(Intellectual Property Disclaimer and Notice: Except for linked URLs and other items available on the Internet in today’s offering, the ideas and opinions above are by PAVACA. Credit must be given to PAVACA if ideas and opinions in today’s offering are used by other blog writers, by podcasters, or in print or social media.)

Health Friday 3.27.2026 Open Thread: HHS is Controlled by Big Pharma, the American Academy of Pediatrics, and the Federal Judiciary

The vintage header image of “The Trial of the Lewis Deer Raiders at Edinburgh” for today’s offering is courtesy of iStock and Google Images.

Health Friday is a series regarding Big Pharma, vaccines, general health, and associated topics. There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: AI-generated items in today’s offering will be cited as such. If readers wish to post AI-generated items in today’s discussion thread, they must cite their source. Thank you.

Today’s offering discusses the recent court ruling by Federal Judge Brian E. Murphy, which as effectively gelded the Centers for Disease Control and Prevention (CDC) division of the United States Department of Health and Human Services (HHS.)

On 16 March 2026, Federal Judge Brian E. Murphy, of Boston, ruled for the plaintiffs in a lawsuit against the CDC, the ACIP group of the CDC (Advisory Committee on Immunization Practices), HHS Secretary Robert F. Kennedy, and other defendants. The lawsuit was brought by a coalition of health organizations, headed by the AAP (American Academy of Pediatrics.) The Murphy ruling, among other items, enjoined the ACIP group from undertaking its scheduled meeting in March, 2026; it stayed any proposed changes to the CDC Childhood Immunization Schedule, changes that were to have been approved at this meeting; and, nullified all recommendations, directives, and other actions, made by the ACIP group since July 2025. Fierce Pharma covered the ruling here: https://www.fiercepharma.com/pharma/judge-pumps-brakes-rfk-jr-vaccine-overhaul-targering-acip-and-cdc-schedule-revamp, Eric Sagonowsky and Fraiser Kansteiner, 16 March 2026.

The ruling by Judge Murphy is here: https://fingfx.thomsonreuters.com/gfx/legaldocs/gdpzawegkvw/03162026vaccine.pdf. The list of plaintiffs, and more coverage of the Murphy ruling, are here: https://www.apha.org/news-and-media/news-releases/apha-news-releases/federal-judge-blocks-immunization-schedule-changes, “Federal Judge Blocks Immunization Schedule Changes, Stays ACIP Member Appointments”, 16 March 2026. Please see the screenshot, below, from this article:

Dr. Jessica Rose, PhD, discussed the ruling here: https://jessicar.substack.com/p/more-on-the-judgy-mcjudgefaceacip-situation, “More on Judge Brian E Murphy/ACIP situation”, 21 March 2026. Please see the screenshots, below, from this article:

Yours Truly went to the article (referred to in the post by Dr. Rose), written by an experienced practicing attorney, regarding the Murphy “ruling.” The attorney is Bobbie Anne Flower Cox, Esq. Her article is here: https://brownstone.org/articles/when-judges-go-rogue/, 23 March 2026. Please see the screenshots from this article, below:

But wait, there’s more! Judge Murphy, in his “ruling”, also “critiqued” each (then)-member of the ACIP group, finding every one of them “lacking” in what he deemed to be the “amount of expertise” to be making any decisions regarding the CDC vaccination schedule. Please see the screenshots from his “ruling”, below: Page 29 and Page 30:

And then, with even more breathtaking condescension, the following, from Page 31 of the Murphy “ruling”:

It appears that the (then)-members of the ACIP group were supposed to “present evidence” to him that they ARE qualified to sit on the committee? And, if the JUDGE deems their “level of expertise” is “lacking”, that the JUDGE can dismiss such members from the committee? Were the credentials of, for example, (then)-ACIP member Dr. Robert Malone not “good enough” for Judge Murphy? — After all, Dr. Malone discovered how mRNA can be “packaged” into a lipid nanoparticle. And why does it appear that Judge Murphy has a “particular axe to grind” regarding (then)-ACIP member Dr. Retsef Levi?

Back to the Bobbie Anne Cox article. It appears the Judge Murphy was doing all he could to find ways to “legislate from the bench.” Please see below, from Ms. Cox’s article:

Regarding the last point, about the American Academy of Pediatrics (AAP) having no standing: Guess what? The AAP gets large donations from Big Pharma entities, such as, Pfizer, Moderna, and, Seqirus. The AAP is completely compromised and should never have been a party to this (bogus) lawsuit in the first place. Please see: https://www.aap.org/en/ways-to-give/current-corporate-and-organizational-supporters/, from 10 October 2025:

The AAP is a direct beneficiary of Big Pharma. AAP pediatrician members make significant amounts of income from “vaccinating” children with products manufactured by the Big Pharma entities that give large amounts of money to the AAP. See how the cycle works?

If, as Attorney Cox states, the Murphy “ruling” can be overturned in court, why did HHS apparently choose NOT to fight the “ruling”, opting instead to “reconstitute” the ACIP group? Please see: https://imahealth.substack.com/cp/191534018, “Breaking News: Chairman Milhoan Confirms that ACIP Disbanded in Response to Federal Court Ruling: Sources Indicate Administration Opts to Reconstitute ACIP Rather Than Appeal”, 16 March 2026. A screenshot from this article is below:

In addition, pediatricians receive “financial incentives” from Big Pharma companies and from insurance companies via programs to ensure that children are “vaccinated.” This, despite the denials and “fact-checking” by media and by organizations such as the AAP about such “incentive payments.” In fact, Texas Attorney General Ken Paxton has initiated an investigation into these payments given to pediatricians in his state. Please see: https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-launches-wide-sweeping-investigation-unlawful-financial-incentives, “Attorney General Ken Paxton Launches Wide-Sweeping Investigation into Unlawful Financial Incentives Related to Childhood Vaccine Recommendations”, 21 January 2026. Please see the screenshot, below, from this article:

There is yet another aspect to the Murphy “ruling” situation: A combination of conflicting statements, apparent miscommunications, and what appears to be personnel from the Oval Office “taking a more active role” in HHS activities. Please see: https://www.fiercepharma.com/pharma/acip-members-miscommunication-vaccine-panels-future-adds-confusion-after-earlier-upset-court, “ACIP member’s miscommunication on vaccine panel’s future adds to confusion about ruling”, 20 March 2026, Fraiser Kansteiner. Please see the screenshots from this article, below:

Note that Yours Truly used the phrase, “appears to be personnel from the Oval Office” related to the HHS situation — the Wall Street Journal cites “unnamed sources.” However, what can be said, with a fair amount of accuracy, is that the HHS (and its CDC and FDA and NIH and NIAID divisions) have been roiling due to the attempts of HHS Sec. Kennedy, Jr., to curtail / stop, the “good old days” in the department. The “good old days” when drugs and “vaccines” were granted EUAs or Full Approval without proper full testing and data analysis; when the CDC “recommended” more and more “vaccines” for children from birth to age 18; when the FDA granted EUAs and Full Approvals for drugs and biologics that were clearly dangerous to patients (VIOXX [pain reliever]; and, Aduhelm [Alzheimer’s disease drug] are cases in point.) What can be said, with a fair amount of accuracy, is that Gain-of-Function experiments in the United States are still being funded by NIH, even though a “ban” on such experiments and funding was declared in 2025 — and, in addition, such experiments are also being conducted by other agencies within the federal government; as, for example, the H5N1 Avian Influenza experiments being conducted at the USDA Southeast Poultry Division facility in Georgia (https://jonfleetwood.substack.com/p/trump-admin-keeps-ties-to-who-influenza, “Trump Admin Keeps Ties to WHO Influenza System as U.S. Funds Bird Flu Gain-of-Function and Mass Vaccine Programs”, 24 January 2026.)

The following are the opinions of Yours Truly:

What the situation is today: Big Pharma, the American Academy of Pediatrics, and the Federal Judiciary, are in control of the Department of Health and Human Services. What the situation is today: HHS has opted to “reconstitute” the ACIP group, instead of fighting the Murphy “ruling” in court — in effect, acquiescing to the “ruling.” This acquiescing “kicks the door off the hinges” for any Federal Judge to stop / stay / delay, any directive, recommendation, committee, or activity of that committee, of the HHS, CDC, or FDA.

What the situation is today: Millions of children, from birth to age 18, are at risk for complications of all kinds induced by the multitude of “vaccines” that they are “recommended” to get according to the old CDC Childhood Immunizations Schedules.

What the situation is today: By HHS Sec. Kennedy, Jr., focusing on creating a new “food pyramid chart”, along with other “side-bar” programs — which, of themselves, are worthy — but not as important as focusing on completely rooting out any influence of Big Pharma and Establishment Medicine at HHS, he has allowed these entities to manipulate the Federal Judiciary into neutering the entire agency. By HHS Sec. Kennedy, Jr., focusing on other programs, he is NOT doing anything substantive regarding completely STOPPING the use of COVID-19 “vaccines” in the United States — arguably, the most dangerous, deadly, and poisonous products ever designed. By HHS Sec. Kennedy, Jr., focusing on other programs, he is NOT doing anything substantive regarding bringing those to account for their roles in creating the COVID-19 virus itself, or the COVID-19 “vaccines.”

What the situation is today: Is is more important then ever for all persons (including parents of children from birth up to age 18) to take charge of their health. To question the “why” behind a “recommendation” by a healthcare professional regarding taking any “vaccine”, let alone any drug. To refuse to take any “vaccine”, or to have any “vaccine” put into their children, that the patient (or patient’s parents) do not approve. To fight to have “vaccine liberty” from school boards, employers, and insurance companies that request “compliance” with “recommendations” or “mandates” for “vaccination.”

What the situation is today: Since Big Pharma, the American Academy of Pediatrics, and the Federal Judiciary are now in control of the Department of Health and Human Services — it is now the responsibility of HHS Sec. Kennedy, Jr., to stop this situation; or, for the current Administration to find someone who will.

What the situation is today: An example of the new “power base” that is in control of HHS / CDC / FDA: Pfizer-BioNTech wants the FDA to approve the company’s new Lyme disease “vaccine” (which appears to be mRNA-based) that it is developing with a French company, Valneva. The “vaccine candidate” is called VLA15. This, despite the fact that the Phase 3 clinical trial for VLA15 did NOT meet its primary outcome goal — which goal was to demonstrate effectiveness. This, despite the fact that the CDC has NOT YET “reconstituted” the ACIP group, which group is SUPPOSED TO RECOMMEND new “vaccines” for authorization or for approval by the FDA. If the FDA does not bow to Pfizer-BioNTech’s request to approve VLA15, what is to stop the company from suing the FDA and, via a Federal Judge (for example, Judge Brian E. Murphy), forcing the agency to approve the “vaccine?” Please see: https://tdefender.substack.com/cp/1921132650, “Pfizer Wants FDA to Approve Its Vaccine for Lyme Disease — But Does It Have a Shot?”, Brenda Baletti, PhD, 25 March 2026.

THERE IS NO PLACE IN THE HUMAN BODY FOR AN mRNA, A modRNA, AN saRNA, OR A taRNA PRODUCT OF ANY KIND, IN ANY FORM.

THERE MUST, FIRST, BE MUCH MORE RESEARCH PERFORMED ON THESE TECHNOLOGIES AND PLATFORMS.

THERE MUST BE, SECOND, EXTENSIVE TESTING OF PRODUCTS USING THESE TECHNOLOGIES AND PLATFORMS, WITH COMPLETE ANALYSES OF SAFETY AND EFFICACY DATA.

ALL GAIN-OF-FUNCTION EXPERIMENTS IN THE UNITED STATES, OF ANY KIND, PERFORMED BY ANY DEPARTMENT OF THE UNITED STATES GOVERNMENT, MUST BE STOPPED.

Peace, Good Energy, Respect: PAVACA

(Intellectual Disclaimer and Notice: Except for linked URLs and other items available on the Internet, the ideas and opinions of today’s offering are by PAVACA. Credit to PAVACA must be given if the ideas and opinions of today’s offering are used by other blog writers, by podcasters, in social or in print media.)

Health Friday 3.20.2026 Open Thread: Meet Moderna’s mRNA-1283, mNEXSPIKE, the Other Component of mRNA-1083, mCOMBRIAX: Part Two

The colorized vintage image of vaccination for today’s header is courtesy of MedPage Today and Google Images.

Health Friday is a series devoted to Big Pharma, vaccines, general health, and associated topics. There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certaincaveats from Yours Truly, of which readers should be aware. They are linked here. Note: AI-generated items in today’s offering will be cited as such. If readers wish to post AI-generated items in today’s discussion thread, they must cite their source. Thank you.

The Moderna “combination modRNA influenza + COVID-19 vaccine”, mRNA-1083, also called mCOMBRIAX, has just been approved for use in Europe. mRNA (mCOMBRIAX) is a combination of the Moderna modRNA multi-strain influenza “vaccine”, mRNA-1010, plus the company’s “other” modRNA COVID-19 bioweapon “vaccine”, mRNA-1283 (mNEXSPIKE.) Yours Truly has written about the mRNA-1010 component of this “combo vaccine” here: https://www.theqtree.com/2026/02/27/health-friday-2-27-2026-open-thread-modernas-mrna-1010-and-the-end-run-around-hhs-sec-kennedy-jr-part-one/; and, https://www.theqtree.com/2026/03/06/health-friday-3-6-2026-open-thread-modernas-mrna-1010-and-the-end-run-around-hhs-sec-kennedy-jr-part-two/. Part One of the discussion of the mRNA-1283 (mNEXSPIKE) component is here: https://www.theqtree.com/2026/03/13/health-friday-3-13-2026-open-thread-meet-modernas-mrna-1283-mnexspike-the-other-component-of-mrna-1083-mcombriax-part-one/.

Today’s offering is Part Two of two regarding mRNA-1283 (mNEXSPIKE.)

The Package Insert for healthcare professionals for mNEXSPIKE is here: https://www.fda.gov/media/186738/download. Below is a screenshot of section 11 Description of this injectable:

Note that the Description does NOT mention that the fact that N1-Methylpseudouridine (either by that name, or by its IUPAC name [its spelled-out chemical components name]) is used in mNEXSPIKE. Nor does it mention that the N1-Methylpseudouridine in mNEXSPIKE serves as the “scaffold” for the mechanism of the “vaccine” — a lab-created element that destroys the RNA of the natural Uridine in the body, replacing it with a compound that does nothing beneficial: in fact, which serves as a “facilitator” in speeding the ingredients of the “vaccine” throughout the entire body; while, at the same time, severely damaging the body’s natural ability (via natural Uridine and its RNA) to regulate mood, help with learning and memory, and assist in normal “gut-brain axis” interactions.

Which leads into the Patent for mNEXSPIKE. Yours Truly will not present the entire Patent. Nor is Yours Truly advising people to read through the Patent document for every drug or “vaccine” they put into their body. However, there are multiple aspects of “the Devil is in the details” in the Patent for mNEXSPIKE regarding the ingredients that “may” be used in formulating this “vaccine” — details that appear to be lacking in the Package Insert. Keep this in mind when reading the following.

There are multiple Moderna-held Patents for mNEXSPIKE (https://www.modernatx.com/en-US/patents.) The most recent Patent is here: https://patents.google.com/patent/US12508278B2/en. The Title of the Patent is: “Lipid nanoparticle compositions and methods of formulating the same.” This Patent was published on 30 December 2025. An image of the Inventors and Dates section is below:

Note that the assigned Agent for this Patent is ARES CAPITAL CORPORATION (https://www.arescapitalcorp.com/), which is private-equity, real estate, and credit asset manager in “global alternative investment” (per Wikipedia.)

The mention of N1-Methylpseudouridine as a component of mNEXSPIKE is here in the Patent:

Which is followed by a list, in Claim 1, of twenty-two different “phospholipids” that Moderna “may” choose from in formulating the “vaccine.” Which list is then followed by a list, also in Claim 1, of nine different PEG-lipids (polyethylene glycol lipids) that Moderna “may” choose from in formulating the “vaccine.” The question here is: Are there different “phospholipids” and/or different “PEG-lipids” being used in different batches of mNEXSPIKE other than the ones listed in the section 11 Description of the Package Insert for the “vaccine”? Recall, from Part One regarding mNEXSPIKE, that the FDA Approval Letter that was sent to Moderna for this injectable specifically stated that the agency relied ONLY on the “data” and other information that Moderna gave to the FDA — there was no independent testing or analysis performed.

Then, there is the lipid nanoparticle (LNP) in mNEXSPIKE, which in the section 11 Description is SM-102. However, in the Patent document, there appear to be multiple types of LNPs from which Moderna “may” choose in formulating the “vaccine.” In addition, there are listed multiple percentage ratio ranges of these LNPs in multiple types of combinations with the PEG-lipids and/or with “non-cationic lipids.” These are in the Patent document under 1. Lipid Nanoparticle Compositions. The question here is: Are there then multiple “variations” of these formulations that would appear in different batches of mNEXSPIKE?

Then, there are the “Adduct Impurities” that are permitted in the formulation of mNEXSPIKE. Please see the screenshot, below, from the Patent, the section 1. Lipid Nanoparticles:

“Adduct impurities” — think the “loose DNA” in the Pfizer-BioNTech and in the Moderna modRNA COVID-19 bioweapon “vaccines.” Think the “Process 2” manufacturing method — and that “culturing bath” of lab-created E. coli derivative that is part of this process — that these companies use as part of modRNA COVID-19 bioweapon “vaccines” production. It appears that Moderna is fine with allowing impurities in mNEXSPIKE. One would think that, after more than five years of manufacturing modRNA COVID-19 bioweapon “vaccines”, the company would have come up with a way to remove impurities; or, at least, to reduce the percentage “allowed” in the “vaccine” to as nearly zero as possible, from the product before putting it on the market — and not allowing a range of percentage amounts of impurities to remain in the product.

Following are screenshots from the Patent US12508278B2 for mNEXSPIKE. Yours Truly believes it appears that Moderna may have submitted “data” to the FDA for approval of this “vaccine” based on only the limited set of ingredients that the company sent “data” about — while, at the same time, the Patent for the “vaccine” contains multiple lists of multiple variations of these ingredients from which the company “may” choose to formulate batches of the “vaccine.” In other words — is a “How Bad is My Batch?”-type of scenario being set up?

The ratio of lipid nanoparticles (LNPs) to the mRNA in mNEXSPIKE is allowed to vary:

The type of pseudouridine used in mNEXSPIKE is allowed to vary:

Which indicates that another pseudouridine OTHER than N1-Methylpseudouridine “may” be used in mNEXSPIKE.

The company reserves the right to substitute codons in the manufacture of mNEXSPIKE. Codons are three-nucleotide sequences of a strand of either DNA or of RNA:

The “rationale” for codon replacements:

Forms of administration for mNEXSPIKE:

Note that the Patent states that the “vaccine” can cross the Blood-Brain Barrier.

In summary: It appears that Moderna, in giving the FDA “data” involving the ingredients listed on the Package Insert for mNEXSPIKE, for which “data” the FDA granted “full approval” last year, did not inform the FDA that the Patent for the “vaccine” contains multiple variations for the ingredients used in the product; multiple variations of formulations for the product; and multiple forms of administration of the product. It also appears that Dr. David Kaslow, who signed the FDA Approval Letter to Moderna for mNEXSPIKE, either did not read the Patent document for this product; or, did not have it summarized for him to read; or, read either or both of the latter and was fine with it.

**** AND HERE’S THE REASON BEHIND THE DISCUSSION OF THE PATENT FOR mRNA-1283 (mNEXSPIKE) AND THE SCREENSHOTS FROM THE PATENT: It appears that Moderna is using clinical trials study subjects as HUMAN LAB RATS in their two latest Clinical Trials of “variant formulations” of mRNA-1283 (mNEXSPIKE.)

Clinical Trial NCT07266558 (https://clinicaltrials.gov/study/NCT07266558.) Please see below: screenshots of the study Overview, and of the Trial Description – Intervention and Study Arms section from the Researcher View:

Note the language, “Variant Formulation.” Note ALSO that this Clinical Trial is for HEALTHY persons age 50 – 64 years with NO underlying conditions — this appears to be the “setup” to getting mNEXSPIKE approved by the FDA for HEALTHY persons under age 65. Note also that mRNA-1273 (SPIKEVAX) may be given to a study subject.

Clinical Trial NCT07089706 (https://clinicaltrials.gov/study/NCT07089706.) Please see below: screenshots of the study Overview, and of the Trial Description – Intervention and Study Arms from the Researcher View:

Note that there is NO saline Placebo group in the clinical trial above. Note also the very small study subject pool (832 persons.)

What are in these “variant formulations” of mRNA-1283 (mNEXSPIKE) that the study subjects will receive in the clinical trials listed above? Refer back to the screenshots from the Patent for mRNA-1283 in today’s offering. Look at the multiple combinations of lipid nanoparticles to modRNA, the multiple types of pseudouridines, the multiple percentage ranges of allowed “adduct impurities” that can be used in formulations of this injectable. Also — Why is there NO saline Placebo group in NCT07089706?

Does anyone at the FDA understand what’s going on here?

THERE IS NO PLACE FOR AN mRNA, A modRNA, AN saRNA, OR A taRNA PRODUCT IN THE HUMAN BODY, IN ANY FORM. THERE MUST, FIRST, BE MUCH MORE RESEARCH PERFORMED ON THESE GENE-ALTERING THERAPY PLATFORMS AND PRODUCTS. THERE MUST, SECOND, BE IRREFUTABLE PROOF THAT PRODUCTS MADE USING THESE THERAPY PLATFORMS AND PRODUCTS ARE TRULY “SAFE AND EFFECTIVE.”

Peace, Good Energy, Respect: PAVACA

(Intellectual Disclaimer and Notice: Other than URLs and related items available on the Internet, the ideas and opinions of today’s offering are by PAVACA. Credit must be given to PAVACA if the ideas and opinions of today’s offering are used by other blog writers, by podcasters, or in social or print media.)

Health Friday 3.13.2026 Open Thread: Meet Moderna’s mRNA-1283, mNEXSPIKE, the Other Component of mRNA-1083, mCOMBRIAX: Part One

The colorized vintage image of vaccination for today’s header is courtesy of MedPage Today and Google Images.

Health Friday is a series devoted to Big Pharma, vaccines, general health, and associated topics. There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: AI-generated items in today’s offering will be cited as such. If readers wish to post AI-generated items in today’s discussion thread, they must cite their source. Thank you.

The Moderna “combination modRNA influenza + modRNA COVID-19 vaccine”, mRNA-1083, also called mCOMBRIAX, has just been approved for use in Europe. mRNA-1083 (mCOMBRIAX) is a combination of the Moderna modRNA multi-strain influenza “vaccine”, mRNA-1010, plus the company’s “other” modRNA COVID-19 bioweapon “vaccine”, mRNA-1283 (mNEXSPIKE.) Yours Truly has written about the mRNA-1010 component of this “combo vaccine” here: https://www.theqtree.com/2026/02/27/health-friday-2-27-2026-open-thread-modernas-mrna-1010-and-the-end-run-around-hhs-sec-kennedy-jr-part-one/; and, here: https://www.theqtree.com/2026/03/06/health-friday-3-6-2026-open-thread-modernas-mrna-1010-and-the-end-run-around-hhs-sec-kennedy-jr-part-two/.

And now, on to the mRNA-1283 (mNEXSPIKE) component of mRNA-1083. Today’s offering is Part One of two:

Moderna’s “other” modRNA COVID-19 bioweapon “vaccine”, mRNA-1283 (mNEXSPIKE), was approved for use in the United States on 30 May 2025. The FDA Approval Letter to Moderna is here: https://www.fda.gov/media/186740/download. The Approval Letter for mNEXSPIKE was signed by David C. Kaslow, MD, Director of the Office of Vaccines Research and Review (a subdivision of FDA’s CBER department [Center for Biologics Evaluation and Research]). Dr. Kaslow is a Biden-era “holdover” at the FDA; he has been with CBER since 11 October 2022.

It appears that Dr. Kaslow relied solely on the “data” that was given to the FDA by Moderna regarding the “safety and efficacy” of mRNA-1283, prior to that agency’s granting approval of the BLA (Biologics License Application) that Moderna submitted for the product. In addition, it appears that Dr. Kaslow believed that the “data” that Moderna supplied to the FDA was sufficient enough to warrant a bypass of the review process by the VRBPAC group of the FDA (Vaccines and Related Biological Products Committee.) Please see the screenshot from Dr. Kaslow’s Approval Letter to Moderna for mRNA-1283 (mNEXSPIKE), below:

By the way, on 20 May 2025, Dr. Martin Makary (FDA Commissioner) and Dr. Vinay Prasad (Director of the FDA’s CBER division) published an “opinion piece” in the New England Journal of Medicine that purported to be their “opinions” regarding a “new approach” to COVID-19 “vaccination” in the United States. However, this was not really an “opinion piece” — it was implemented as FDA policy. This article by Dr. Prasad and Dr. Makary was published just 10 days before Dr. Kaslow sent the Approval Letter to Moderna for mRNA-1283 (mNEXSPIKE.) Did Dr. Prasad and Dr. Makary know in advance that Dr. Kaslow was going to issue this Approval Letter? Did HHS Secretary Kennedy, Jr., know? The “opinion piece” is here: https://doi.org/10.1056/NEJMsb2506929. “An Evidence-Based Approach to COVID-19 Vaccination.” Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH. 20 May 2025. Below are two screenshots from this article: from the text; and, the Figure 2, which lists the “groups at severe risk from COVID-19.” The persons who would fall under one or more of the categories listed in Figure 2, even if these persons are under age 65, would “qualify” for “vaccination” with mNEXSPIKE:

The Package Insert for healthcare professionals for mRNA-1283 (mNEXSPIKE) is here: https://www.fda.gov/media/186738/download. Please see the screenshots of the following sections of this Package Insert, below: first, section 11 Description; then, section 12 Clinical Pharmacology, and section 13 Nonclinical Toxicology:

It would appear that Dr. Kaslow was comfortable in approving an injectable by Moderna (mRNA-1283, also called mNEXSPIKE) that contains the dangerous lipid nanoparticle SM-102; that contains at least PEG-related element (polyethylene glycol); and, that was not tested for carcinogenicity (the potential to cause cancer), for genotoxicity (the potential to damage genes, or to cause changes to genes, either of which can also cause cancer), or for impairment of male fertility.

It would also appear that Dr. Kaslow was comfortable with approving this modRNA COVID-19 bioweapon “vaccine” (mRNA-1283, also called mNEXSPIKE), which is purported to “prevent infection of COVID-19” — but, which claim has been proven to be wrong. From the FDA Package Insert for mNEXSPIKE:

The “prevent coronavirus disease 2019 (COVID-19)” statement is still being used by the FDA on COVID-19 bioweapon “vaccines” Package Inserts, despite the fact that Shrestha, et al., demonstrated in 2023 that “fully up-to-date vaccinated” Cleveland Clinic employees were more likely to become COVID-19 infected than those who were not “fully up-to-date” with COVID-19 “vaccination” (https://doi.org/10.1101/2023.06.09.23290893. “Risk of Coronavirus Disease (COVID-19) Among Those Up-to-Date and Not Up-to-Date on COVID-19 Vaccination.” Nabin K. Shrestha, et al. 13 June 2023.) Please the screenshot from this paper, below:

Why aren’t the Moderna “original” modRNA COVID-19 bioweapon “vaccine”, mRNA-1273 (SPIKEVAX), and the Moderna modRNA COVID-19 bioweapon “vaccine”, mRNA-1283 (mNEXSPIKE), the same? Please see the screenshot, below, from this article (https://www.drugs.com/medical-answers/what-difference-between-spikevax-mnexspike-3580787/, “What is the difference between SPIKEVAX and mNEXSPIKE?”, 2 September 2025:

However, regarding mNEXSPIKE, there apparently is a “blurred line” as to the use of it in persons under age 65 who do not have an “underlying medical condition.” Please see the screenshot below, from this article: https://health.mountsinai.org/blog/heres-what-you-need-to-know-about-the-new-covid-19-vaccines/, 23 September 2025; the advice is from Dr. Bernard Camins, MD, MSc, of Mount Sinai Hospital, in the “FAQ” section:

Note the language above, from Dr. Camins, regarding the ability of pharmacists to “prescribe vaccines off-label.”

Why is the N-terminal domain of the SARS-CoV-2 virus so important to Moderna that the company crafted a modRNA COVID-19 bioweapon “vaccine”, mNEXSPIKE, to utilize it? The N-terminal domain area is the “closest” (in terms of placement) to the receptor-binding domain (RCB) on the SARS-CoV-2 virus code. The N-terminal domain is also close to the S1/S2 cleavage site on the virus code. The receptor-binding domain is the part of the virus code that “makes sure” that the “payload” of the “vaccine” binds itself (enters into) the cells of the “vaccinated” person. These, in this writer’s opinion, make the N-terminal domain a “prime target” for the development of modRNA COVID-19 bioweapon “vaccines” that do not need to include the entire virus code, but still can “deliver the payload” through the receptor-binding domain mechanism. Please see: https://doi.org/10.3389/fcimb.2020.587269. “SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.” Mei-Yue Wang, et al. 24 November 2020. Figure 1.) This is in contrast to the other modRNA COVID-19 bioweapon “vaccines” (by Moderna and by Pfizer-BioNTech) that contain the entire spike protein sequence (S1 and S2 areas.)

The issue regarding developing a modRNA COVID-19 bioweapon “vaccine” that only utilizes the N-terminal domain and the receptor-binding domain appears to have been determining exactly what “binding pocket” of the N-terminal domain would work. Scientists had been experimenting with the N-terminal domain to find such a “binding pocket”: for example, as described in this paper, from 2022: https://doi.org/10.1016/j.csbj.2022.11.004. “Structural and energetic analyses of SARS-CoV-2 N-terminal domain characterise sugar binding pockets and suggest putative impacts of variants on COVID-19 transmission.” Jonathan Lees, et al. 17 November 2022. Please see the screenshots from this paper, below; first, the Abstract; followed by the Graphical Abstract:

It appears that Moderna did find such an N-terminal “binding pocket” to use for the development of mNEXSPIKE. And, it appears that the company’s decision to “harness” the mechanism to the S1 area of the SARS-CoV-2 spike protein, as opposed to using the entire S1/S2 sequence, is due to the fact that the S1 area is that which appears to be the most “effective” in regards to the Delta and Omicron variants of the virus. Please refer to: https://pubmed.ncbi.nlm.nih.gov/38034565. “SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants.” Tarlan Mamedov, et al. 14 November 2023. Please see the screenshot, below, of the Conclusion from this paper:

Note that Mamedov, et al., used a tobacco plant to produce the S1 protein from SARS-CoV-2, which they then tested against Delta and Omicron virus variants.

In this writer’s opinion, mRNA-1283 (mNEXSPIKE) cannot be thought of as “mRNA-1273 (SPIKEVAX) Lite.” mNEXSPIKE contains the S1 spike protein of an Omicron variant of SARS-CoV-2. mNEXSPIKE contains the dangerous lipid nanoparticle, SM-102, that mRNA-1273 (SPIKEVAX) also contains. mNEXSPIKE contains N1-Methylpseudouridine (which will destroy the RNA of the “vaccinated” body’s natural Uridine, replacing it with a lab-created chemical compound that has no natural, beneficial mechanism for the body), which mRNA-1273 (SPIKEVAX) also contains. In this writer’s opinion, the only difference between mRNA-1273 (SPIKEVAX) and mNEXSPIKE is that the latter “vaccine” does not contain the S2 area of the spike protein.

To be continued in Part Two.

THERE IS NO PLACE IN THE HUMAN BODY FOR AN mRNA, A modRNA, AN saRNA, OR A taRNA PRODUCT OF ANY KIND, IN ANY FORM. THERE MUST, FIRST, BE MUCH MORE RESEARCH INTO THESE GENE-ALTERING THERAPY PLATFORMS AND PRODUCTS. THERE MUST, SECOND, BE IRREFUTABLE PROOF THAT THESE GENE-ALTERING THERAPY PLATFORMS AND PRODUCTS ARE TRULY “SAFE AND EFFECTIVE.”

Peace, Good Energy, Respect: PAVACA

(Intellectual Disclaimer and Notice: Other than URLs and related items available on the Internet, the ideas and opinions of today’s offering are by PAVACA. Credit must be given to PAVACA if the ideas and opinions of today’s offering are used by other blog writers, by podcasters, or in social or print media.)

Health Friday 3.6.2026 Open Thread: Moderna’s mRNA-1010 and the End Run Around HHS Sec. Kennedy, Jr.: Part Two

The header image for today’s offering of an end run is courtesy of Grammarist and Google Images.

Health Friday is a series devoted to information regarding Big Pharma, vaccines, general health, and other topics.

There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie;, and certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: Yours Truly has checked today’s offering for AI-generated content; to the best of her knowledge and belief, there is none. If readers wish to post AI-generated content in today’s discussion thread, they must cite their source. Thank you.

Special Note regarding today’s offering: In Yours Truly’s opinion, it is very important that HHS Sec. Robert F. Kennedy, Jr., gets the URL link to today’s post. Please help in this regard if possible. Thank you. https://x.com/SecKennedy; https://truthsocial.com/@seckennedy; https://www.instagram.com/seckennedy/.

Part One of the series is here: https://www.theqtree.com/2026/02/27/health-friday-2-27-2026-open-thread-modernas-mrna-1010-and-the-end-run-around-hhs-sec-kennedy-jr-part-one/.

Part Two of the series, today’s offering, discusses two very important areas related to mRNA-1010, Moderna’s modRNA-based influenza “vaccine”, the (amended) BLA (Biologics License Application) for which the FDA has agreed to review, after the agency first refused to file the original BLA. The first area is the Patent document for mRNA-1010. The second area is the involvement of Blackstone Life Sciences in funding mRNA-1010.

**** Preliminary item before the first discussion area; keep this in mind regarding anything related to mRNA-1010: The EMA (European Medicines Agency) has just approved the use of Moderna’s COMBO modRNA “vaccine”, mRNA-1083, for use in the European Union. mRNA-1083 is combination of Moderna’s modRNA “vaccine” of multiple influenza strains, mRNA-1010 — PLUS, Moderna’s modRNA COVID-19 “vaccine”, mRNA-1283 (mNEXSPIKE.) Please see: https://www.stocktitan.net/news/MRNA/european-medicines-agency-s-committee-for-medicinal-products-for-rod4htf7c1gd.html, “European Medicine Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19”, 26 February 2026. mRNA-1083, also called mCOMBRIAX, is the “end-product” that Moderna is pushing to have the FDA approve for use in the United States. The first step in this process was to get FDA approval for the mRNA-1283 component, mNEXSPIKE. which the agency did on 30 May 2025. The next step is for Moderna to get FDA approval for the mRNA-1010 component.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

First discussion area of today’s offering: THE PATENT DOCUMENT FOR mRNA-1010:

The Patent document for mRNA-1010 is found here: https://patents.google.com/patent/EP4274607A1/en. Note that this Patent was filed under a European Patent listing. The Patent listing screenshot is below, followed by a screenshot of the Title and the Abstract:

Yours Truly will not go through the entire Patent document for mRNA-1010. However, the screenshots of sections of the Patent document, below, are important, as they show what, in this writer’s opinion, are decisions by Moderna to lab-create an mRNA-based influenza virus “vaccine” that has multiple strains of virus and lipid nanoparticles variations — only a few of which “vaccine” formula variations could have been fully tested and the test results analyzed, either in lab mice experiments or in human clinical trials, before March 2026.

The Patent document for mRNA-1010 is what Yours Truly calls a “kitchen-sink” document. It lists and describes multiple modRNA-based influenza strains that “may” be used in the formulations of the “vaccine.” It lists multiple possible formulations for the lipid nanoparticles that “may” be used the formulations for the “vaccine.” It lists the multiple combinations of amounts of the modRNA-based influenza strains antigens that “may” be used in the formulations of the “vaccine.” These multiple variations and formulations are called embodiments in the Patent document.

Example: It appears that up to EIGHT (or more) different modRNA-based strains of influenza viruses “may” be used:

Example: It appears that multiple variations of modRNA strains ratios (from HA antigens or from NA antigens) “may” be used in the EIGHT strain “version”, such as 2:2:2:2:1:1:1:1;, or, as 3:3:3:3:1:1:1:1. Among others:

Which is also described in the Claims section of the Patent document; see below:

Note: “HA” refers to hemagglutinin, an influenza virus surface protein, assists virus particles to “attach” to red blood cells; “NA” refers to neuraminidase, an influenza surface protein that assists in virus replication.

Example: It appears that multiple types of lipid nanoparticles “may” be used in the multiple types of “vaccine” formulations; such, SM-102 (an “ionizable lipid”, already used in SPIKEVAX and in mNEXSPIKE); DOPE; SDPC; PDG-DMG; plus, OTHER types of lipid nanoparticles that Moderna will create for use:

Note that various types of pseudouridines, including N1-Methylpseudouridine (also used in SPIKEVAX and in mNEXSPIKE) “may” be used in the “vaccines” formulated.

Example: It appears that Moderna will determine how many modRNA-based influenza strains will be used in the “vaccine.” Moderna will also determine how many types of lipid nanoparticles (LNPs) will be used in the various “vaccine” formulations:

Note the language that TWELVE OR MORE influenza strains “may” be used in the “vaccine.”

**** Yours Truly will again stress that the European Medicines Agency (EMA) has just approved the Moderna “combo-vaccine”, mRNA-1083 (mCOMBRIAX), for use in Europe. mRNA-1083 contains mRNA-1010, plus mRNA-1283 (mNEXSPIKE, Moderna’s other modRNA COVID-19 bioweapon “vaccine” [the other being its “SPIKEVAX” product].) Look again at the details from the Patent document for mRNA-1010, above. How can a “vaccine” like mRNA-1010 be approved for use anywhere, given that Moderna can choose anywhere from ONE to TWELVE different modRNA-based influenza strains, plus ONE or MORE types of lipid nanoparticles, along with combining these in MULTIPLE FORMULA VARIATIONS, to produce this injectable?

Further down in the Patent document, there is the section Table 5. Experimental Groups. It is in this section that there is detailed discussion of the lab mice experiments with all three of the Moderna “mRNA-10….-vaccines” group, which comprises mRNA-1010, mRNA-1020, and mRNA-1030. This section describes the various influenza strains combinations used in these experiments:

From the section Pharmaceutical Formulations, it appears that Moderna will be using what Yours Truly will call the “crapshoot method” for choosing the amounts of ingredients to be combined into mRNA-1010:

And, from the Titer subsection of the above, it appears that Moderna will also use the “crapshoot method” to estimate (guesstimate) the amount of titer in the blood of a person “vaccinated” with mRNA-1010:

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

What is a possible “underpinning” to the “multiple options” for Moderna’s mRNA-1010 formulation? Perhaps it is this 2023 article: “Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses.” Jefferey K. Taubenberger, David M. Morens, Anthony S. Fauci. https://pmc.ncbi.nlm.nih.gov/articles/PMC9832587/. 11 January 2023. Please see the screenshots from this article, below. First, the Abstract:

Next, from the Introduction:

Finally, from the section Mucosal responses:

If Yours Truly read this paper correctly, the main idea appears to be the development and use of modRNA-based “vaccines” to be administered intranasally. Note also that Dr. Jeffery K. Taubenberger, one of the paper’s co-authors, is now the Acting Director of the NIAID; and, who holds the Patent for the “universal influenza vaccine” that he invented in 2020 while working at NIH.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Second discussion area of today’s offering: The involvement of Blackstone Life Sciences in the financial backing for mRNA-1010. Yours Truly begins here, with screenshots from the Moderna Earnings Call Transcript published by The Motley Fool on 13 February 2026 (https://www.fool.com/earnings/call-transcripts/2026/02/13/moderna-mrna-q4-2025-earnings-call-transcript/); first, the Date and Participants section; then, a portion of the Takeaways section; and, the Risks section:

Thanks to The Motley Fool for the above information.

Moderna has realized that their United States COVID-19 bioweapon “vaccine” market, and their modRNA-based influenza “vaccine” market, are shrinking. There were income losses for the company. Meanwhile, Moderna has multiple other injectable products “in the pipeline” for development and testing prior to submitting applications to the FDA for BLAs for these products. This, then, presents an issue regarding the funding of the company’s endeavors.

It appears that Moderna has found a solution to two of these issues — the situations with funding; and, with developing mRNA-1010 and with mRNA-1083 to get these products approved for use: the company obtained an “infusion” of up to $750 Million dollars from Blackstone Life Sciences in 2024: https://pharmaphorum.com/news/blackstone-bankrolls-modernas-flu-shot-750m, “Blackstone bankrolls Moderna’s flu shot for $750m”, Phil Taylor, 28 March 2024. Please see the screenshot from this article, below:

Note closely the language in the article screenshot above related to Blackstone Life Sciences receiving future “rights and royalties payments” from Moderna for the sales and use of mRNA-1010 (the multi-strain and multi-LPN modRNA influenza “vaccine” being considered by the FDA for approval), and of mRNA-1083 (the combination modRNA “vaccine” of mRNA-1010 plus mRNA-1283 [mNEXSPIKE, modRNA COVID-19 bioweapon “vaccine”], which was just approved in Europe this month.)

What is Blackstone Life Sciences? It is a subsidiary of Blackstone, an international asset-management and acquisition company that currently has over $1Trillion dollars in managed assets: https://www.blackstone.com/the-firm/. Please see the screenshot from this website, below; “AUM” = Assets Under Management:

The Blackstone Life Sciences subsidiary was founded in 2005. The headquarters location is: 314 Main St., 15th Floor, Cambridge, MA, 02142. Please see the screenshot showing the Blackstone Life Sciences investment in Moderna on 15 March, 2024, below, per https://pitchbook.com/profiles/investor/11151-91#investments:

The above information, with thanks, is from the non-subscriber website page on Blackstone at Pitchbook.

Is it remotely possible that Moderna is under pressure to “make good” regarding the potential for rights and royalty payments to Blackstone Life Sciences for the sales and use of mRNA-1010 and of mRNA-1083? Is it remotely possible that this is what is behind the pushing by Moderna (which was ultimately successful) in the FDA’s sudden reversal of the Refusal to File letter for the BLA for mRNA-1010, and that agency’s subsequently agreeing to consider an “amended” BLA for this “vaccine”? Is it remotely possible that Moderna (and/or Blackstone Life Sciences) regard the huge potential of the United States market to be important in terms of “Return on Investment” — regardless of the potential for “vaccine”-induced damages from mRNA-1010 and/or mRNA-1083?

Is it remotely possible that the FDA — and Dr. Martin Makary, FDA Commissioner — do not realize that they are being used as pawns in a kind of “vaccine chess game” being played by Big Pharma and Big Investment entities? Has Dr. Makary read the Patent for mRNA-1010, or had it explained to him?

THERE IS NO PLACE IN THE HUMAN BODY FOR AN mRNA-BASED, modRNA-BASED, saRNA-BASED, OR taRNA-BASED PRODUCT IN ANY FORM.

Peace, Good Energy, Respect: PAVACA
(Intellectual Property and Disclaimer: Except for items cited above that are available on the internet, the ideas and opinions of today’s offering are by PAVACA. Credit must be given to PAVACA if the ideas and opinions of today’s offering are used by other blog writers, by podcasters, in social or print media, or in any other form.)

Health Friday 2.27.2026 Open Thread: Moderna’s mRNA-1010 and the End Run Around HHS Sec. Kennedy, Jr.: Part One

The header image for today’s offering of an end run is courtesy of Grammarist and Google Images.

Health Friday is a series devoted to information regarding Big Pharma, vaccines, general health, and associated topics.

There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: Yours Truly has checked today’s offering for AI-generated items; to the best of her knowledge and belief, there are none. If readers wish to post AI-generated items in today’s discussion thread, they must cite their source. Thank you.

Today’s offering is Part One regarding the current situation with Moderna’s latest entry into the mRNA-based “vaccine” platform: the company’s influenza “vaccine”, mRNA-1010.

On 11 February 2026, Dr. Vinay Prasad, director the CBER division of the FDA (Center for Biologics Evaluation and Research) sent an RTF letter (Refusal to File letter) to Moderna in response to that company’s BLA application (BIologics License Application) review request for mRNA-1010, a modRNA-based “vaccine” against several strains of influenza. Dr. Prasad cited the lack of a true placebo control group in a study by Moderna using this “vaccine candidate.” Please see the screenshots, below, from https://pharmacally.com/fda-issues-refusal-to-file-letter-for-modernas-mrna-1010-flu-vaccine/, 11 February 2026:

However, by a few days later, the situation had changed completely: the FDA “reversed course”, agreeing to review Moderna’s BLA (amended) application for mRNA-1010.

By 18 February 2026, a “Type A” meeting had been arranged between the FDA and Moderna regarding the RTF letter. Moderna agreed to submit an “amended” BLA application to the FDA for mRNA-1010. The FDA accepted the amended BLA application. The FDA will make a final decision on approving mRNA-1010 by 5 August 2026. Please see the screenshot, below, from https://www.biospace.com/fda/fda-reverses-course-on-modernas-mrna-flu-shot-application-promising-august-decision, Heather McKenzie, 18 February 2026:

Note: A Type A meeting at the FDA is a “high-priority” meeting; sometimes, Type A meetings are called “milestone meetings.” Per https://facetlifesciences.com/ and https://seed.nih.gov/ searches.

Please see the screenshots, below, on this “volte-face” from https://www.thefocalpoints.com/p/fda-reverses-course-will-now-review, “FDA Reverses Course, Will Now Review Moderna’s Controversial mRNA Flu Vaccine”, Peter A. McCullough, MD, MPH, 20 February 2026:

Then, from https://www.biopharmadive.com/news/fda-reverses-course-review-moderna-approval-application-influenza-812432/, “FDA reverses course on Moderna’s flu vaccine”, Delilah Alvardo, 19 February 2026 (the quotation in the screenshot is from Mani Foroohar):

Note that last sentence, by Mr. Faroohar. It clarifies three “behind-the-scenes” aspects of mRNA-1010:

**** One: That Moderna will do whatever it takes to get mRNA-1010 approved — including being “more assertive” with the FDA, and arranging it so that the FDA will “work with” Moderna.

**** Two: That Moderna will do a “post-marketing study” on mRNA-1010 AFTER it is FDA-approved — meaning that ANYONE who takes mRNA-1010 AFTER the FDA approves it is being treated as a “human lab rat” by Moderna. This is the same type of situation that occurred when the FDA approved Moderna’s modRNA COVID-19 bioweapon “vaccine”, mRNA-1273.

**** Three: That Moderna considers the FDA approval of mRNA-1010 as the “stepping-stone” to what the company appears to believe is the “Holy Grail” of modRNA-based “vaccines” — the company’s “combo” modRNA-based influenza + modRNA-based COVID-19 “vaccine”, mRNA-1083 (the clinical trials for which have been completed)

There are, in addition, two other aspects to the situation: What appears to be pressure on Dr. Martin Makary, MD (FDA Commissioner) to “knuckle under” to what Moderna wants; and, what appears to be a coordinated campaign to have Dr. Vinay Prasad removed from his position as CBER division director at the FDA. In Yours Truly’s opinion, these relate to the “sudden arrangement” of the FDA “Type A” meeting between Moderna representatives and the FDA almost immediately after the Refusal to File was issued by Dr. Prasad. Please see the screenshots, below, from https://www.biospace.com/fda/makary-prasad-under-fire-as-fda-turmoil-reaches-president-trump, Heather McKenzie, 20 February 2026:

Peter Pitts, by the way, was an FDA employee whose position was that of a “senior communications and policy adviser” of the agency (https://www.centerforbiosimilars.com/authos/peter-pitts.) It appears that Mr. Pitts and CMPI are involved in a campaign to have Dr. Prasad removed from the FDA.

In Yours Truly’s opinion: Dr. Martin Makary is compromised, due to his involvement with BIO.org/, the group that is implementing a campaign to have HHS Sec. Robert F. Kennedy, Jr., removed; and, Dr. Prasad is compromised, due to what appears to be lack of support within FDA, combined with innuendoes regarding his professional behavior at the agency.

In Yours Truly’s opinion, It appears that there is a combination of chaos, mistrust, internecine feuding, and active resistance going on within the FDA; plus, exterior pressure on the agency from companies and other entities to restore the FDA back to the “good old days”, when drugs and other biologics were authorized and approved in what may be called a kind of “rubber-stamp” process. It also appears that HHS Sec. Kennedy, Jr., is either being “kept out of the loop” regarding what is going on with the FDA; or, cannot, for whatever reason, root out personnel within the FDA who are fomenting trouble.

Yours Truly now turns to the Moderna-funded published paper on mRNA-1010, which was cited by Dr. Prasad as the reason for his issuing the Refusal to File letter to the company: https://doi.org/10.1038/s41541-025-01340-5. “mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted inactivated vaccines.” Paulina Kaplonek, et al. 15 December 2025. Moderna completely funded this study; all of the paper’s co-authors are either current or former Moderna employees; and, the current Moderna employees who are co-authors of the paper are also stockholders in the company. All of these in and of themselves, in Yours Truly’s opinion, represent massive conflicts of interest that should, under normal circumstances, disqualify the paper from any serious consideration by the FDA for a BLA application review. This is aside from the flaws in the clinical trial NCT05397223, on which the paper was based (more on this below in today’s offering.) Please see the screenshots from this paper, below:

Note the use of the word, “may.” This word is used in several areas of the paper, as in, “may elicit”; “may reflect”; and, “may induce.” In other words, Moderna does not KNOW if mRNA-1010 can actually be helpful against influenza. The company is guessing that it “may.” However, the company is still pursuing the BLA application with the FDA to get the “vaccine” approved — without having provided ANY proof that the “vaccine” actually does what it is “supposed” to do — which is, to prevent influenza infection better than the licensed influenza “vaccines” already on the market.

The following screenshots from the paper relate to how mRNA-1010 works, including: Figure 4B and Figure 4D, which show that the “vaccine” minimizes the crucial natural body’s activity of IgM cells (the “recognize an enemy and signal the other cells” immune cells); which show that there is an apparent increase of IgG4 cells (the “tolerate but never clear” cells); and, which appear to hint at mRNA-1010 being used as a kind of “universal influenza vaccine” candidate:

The blue image is the results of the “comparator influenza vaccine”, FLUAD; the red image is the results of mRNA-1010.

Then, from the section that discusses the results of Figure 4B and Figure 4D:

The Moderna paper co-authors did not prove that mRNA-1010 provides mucosal protection from influenza.

Following is a screenshot from the paper regarding the non-involvement of IgM cells induced by mRNA-1010:

Followed by the “hint” that mRNA-1010 may be used as a “universal influenza vaccine” candidate:

Finally, the Acknowledgements section, and the Ethics Declarations section, of the paper:

As shareholders in Moderna, the above employees (and co-authors of the paper on mRNA-1010) stand to make money off the sale and use of this “vaccine.”

**** Regarding the clinical trial which was the foundation for the Moderna paper that was published on 15 December 2025, NCT05397223, details of which are found here: https://clinicaltrials.org/study/NCT05397223. This clinical trial did NOT have a true saline placebo Control Group. Per the Clinical Trials website, there are TWO separate parts to the study. In Part One, study subjects received injections of: of mRNA-1345 (a modRNA-based “vaccine” against RSV); or, of mRNA-1647 (a modRNA-based “vaccine” against Cytomegalovirus);, or, of mRNA-1273 (the modRNA COVID-19 “vaccine”), all by Moderna. In Part Two, study subjects received injections of either: FLUAD (the “comparator” licensed inactivated influenza vaccine by Seqirus); or, of mRNA-1010. Please see the screenshot, below, from the Clinical Trials website for NCT05397223, the Secondary Outcomes Measures section:

However, there is not a single word in the Moderna-funded paper cited above in which the outcomes for ANY of the “vaccines” used on the study subjects other than FLUAD or mRNA-1010, are found. Nothing for mRNA-1345, for mRNA-1647, or for mRNA-1273. It is unknown if any of these three “vaccines” induced any interactions with either FLUAD or with mRNA-1010. There are “No Results Posted” on the Clinical Trials website for NCT05397223.

Moderna has been in the process of developing and testing mRNA-1010 for the past several years. The company applied pressure, which apparently went all the way up to the Oval Office, in order to force the FDA to reverse course and agree to review the (amended) BLA application for mRNA-1010, despite the flaws of the clinical trial NCT053972723, and despite the Refusal to File letter sent by Dr. Vinay Prasad.

To be continued in Part Two.

THERE IS NO PLACE IN THE HUMAN BODY FOR AN mRNA-BASED, modRNA-BASED, saRNA-BASED, OR taRNA-BASED PRODUCT IN ANY FORM.

Peace, Good Energy, Respect: PAVACA

(intellectual Property Disclaimer and Notice: With the exception of linked items that are found on the internet, the ideas and opinions of today’s offering are by PAVACA. Credit must be given to PAVACA if ideas or opinions in today’s offering are used by other blog writers; by podcasters; or in social or print media.)

Health Friday 2.20.2026 Open Thread: Pfizer-BioNTech COVID-19 modRNA “Vaccine” Negative Effects Proven Ongoing Over Three Years Post-Injection: Part Three

The header image of 1955 vintage Pfizer penicillin bottles is courtesy of Pond5 and Google Images.

Health Friday is a series devoted to information on Big Pharma, vaccines, general health, and associated topics. As today’s offering speaks to the negative effects and outcomes of the modRNA COVID-19 BIOWEAPON “vaccines”, Yours Truly dedicates it to all persons, of whatever age or location, who have suffered, and/or continue to suffer, injuries, illnesses, or disabilities induced by these “vaccines” that they took; and, to those who have passed away from the negative effects and outcomes induced by these “vaccines” that they took.

There are Important Notifications by our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: If there is AI-generated content in today’s offering, it will be labeled as such. If readers wish to post AI-generated content in today’s discussion thread, they must cite their source. Thank you.

Today’s offering is Part Three of three. The previous two parts of this series are here: https://www.theqtree.com/2026/02/06/health-friday-2-6-2026-open-thread-pfizer-biontech-covid-19-modrna-vaccine-negative-effects-proven-ongoing-over-three-years-post-injection-part-one/; and, https://www.theqtree.com/2026/02/13/health-friday-2-13-2026-open-thread-pfizer-biontech-covid-19-modrna-vaccine-negative-effects-proven-ongoing-over-three-years-post-injection-part-two/.

The Hulscher, McCullough, et al., paper that is the basis for this series is here: https://zenodo.org/records/18460099. “Unprecedented Persistence of Vaccine mRNA, Plasmid DNA, Spike Protein, and Genomic Dysregulation Over 3.5 Years Post-COVID-19 mRNA Vaccination.” Nicolas Hulscher, MPH, Peter A. McCullough, MD, MPH, et al. 2 February 2026.

Today’s offering will discuss the findings of ongoing heart / cardiovascular damage induced by the Pfizer-BioNTech COVID-19 modRNA “vaccine”, BNT162b2, in the patient described in the above-cited paper. Below, from the paper, are screenshots of sections that discuss the heart and cardiovascular damage that was found in the patient well after he took this “vaccine”:

The results of the patient’s home-administered cardiac readout tests:

As can be seen, the evidence of irregular heart rhythm are unmistakable. However, refer to the text above — the symptoms were apparently dismissed as “unlikely” for myocarditis / pericarditis, even though Emergency Room visit records when the patient presented there appear to show otherwise.

Continuing, from the paper:

Finally, a cardiac MRI was performed, which confirmed symptoms “consistent with COVID-19 vaccine-induced myocarditis…”; see below, a reduced image from the paper:

The following are several scientific papers and articles. The first one is the 1992 paper by Dr. Ralph Baric, PhD, of the results of his experiments to induce myocarditis and Congestive Heart Failure (CHF) in rabbits that he injected with a rabbit coronavirus (https://academic.oup.com/jid/article/165/1/134/986090. “An Experimental Model for Myocarditis and Congestive Heart Failure after Rabbit Coronavirus Infection.” Ralph S. Baric, et al. January 1992.) Please see the screenshots from this paper, below. First, the general summary:

Followed by two portions from the Discussion section. “RbCV” = rabbit coronavirus.

Following is a look at Reference paper number 17, cited several times in the Baric, et al., paper above. Reference paper number 17 is found here: https://pmc.ncbi.nlm.nih.gov/articles/PMC2042305/. “Rabbit cardiomyopathy associated with a virus antigenetically related to human coronavirus strain 229E.” Small, JD, Aurelian, L., Squire, R.A., et al. June 1979. The following screenshots are from this paper. First, the general summary:

Then, from the Discussion section:

Note the mention of human coronavirus 229E and its potential for “cross-reactivity” with other coronaviruses, including gastroenteritis in swine. Recall that Dr. Ralph Baric, PhD, invented the “No See-m’s” method for “seamless assembly” of chimeric (lab-created) virus code pieces using the TGEV virus (swine transmissible gastroenteritis virus) model back in 2000 (https://journals.asm.org/doi/10.1128/jvi.74.22.10600-10611.2000. “A strategy for the assembly of large RNA and DNA genomes: the transmissible gastroenteritis virus model.” Ralph Baric, et al. 2000.)

Dr. Joseph Sansone, PhD, a psychotherapist in Florida, speaks to the COVID-19 modRNA “vaccines” causing heart disease, immune system conditions, and more, here: https://usawatchdog.com/world-ignoring-disaster-of-cv19-bioweapon-vax-dr-joe-sansone/, 8 February 2026. Dr. Sansone links to the Hulscher, McCullough, et al., article cited above in today’s offering. Please see the screenshot below, from this article:

There is an earlier article discussing heart damage — at the mitochondrial level — that is induced by the COVID-19 “vaccines”, at The Focal Points, here: https://www.thefocalpoints.com/p/spike-protein-exhausts-cardiomyocyte, “Spike Protein Exhausts Cardiomyocyte Mitochondria”, 8 September 2024. The paper referred to in this article is here: https://doi.org/10.3390/cells12060877. “Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19.” Tin Van Huynh, et al. 11 March 2023.

Yours Truly believes that the Hulscher, McCullough, et al., February 2026 paper cited in today’s offering is of incalculable importance. This paper proves that these negative effects and outcomes in “vaccinated” persons can be found more than three years post-“vaccine” injection. This paper proves that an individual “vaccinated” person can present with numerous negative effects and outcomes induced by these “vaccines.” Yours Truly expresses deep appreciation of Dr. McCullough and his colleagues in working with this patient in the long and laborious testing that had to be performed in order to come to the correct diagnoses for the patient; and, from there, coming up with a treatment plan.

The Hulscher, McCullough, et al., February 2026 paper proves that there is risk of multiple types of negative effects and outcomes from having this “vaccine” in the body — damage that can be found years after the “vaccine” is injected into the body, and that can extend to the brain. This risk pool includes those who take the “latest version COMIRNATY COVID-19 vaccine”.

Yours Truly will make it clear that the patient in the Hulscher, McCullough, et al., February 2026 paper took three injections of BNT162b2: two in March 2021 (3 March and 24 March); and, the “booster” injection on 20 February 2022 — then did not take any further injections. The damage to his body and the accompanying associated emotional/psychological effects on him were traced back to these three injections over 3.5 years later. What about the millions upon millions of persons who took the BNT162b2 “primary series” of two injections back in 2021, then the original BNT162b2 “booster” injection in 2022, and then have taken injections of the BNT162b2 “descendant clone COVID-19 vaccines” (under the brand name, COMIRNATY), since the year 2022? What about the persons who have taken six injections so far of this Pfizer-BioNTech injectable — the “primary series” of two injections in 2021 + the “original booster injection” in 2022 + the 2023 “COMIRNATY booster” + the 2024 “COMIRNATY booster” + the 2025 “COMIRNATY booster”? If one person who took only three of the Pfizer-BioNTech COVID-19 “vaccine” injectables (the patient in the Hulscher, McCullough, et al., paper) and presents with multiple negative effects and outcomes over 3.5 years after stopping taking the injections — what about the millions of persons who have a total of at least six Pfizer-BioNTech (COMIRNATY) injections in their bodies as of now? If the potential for multiple negative effects and outcomes from the Pfizer-BioNTech COVID-19 injectables can be found in a “vaccinated” person over three years post-final injection, what is the potential for “rolling accumulated negative effects and outcomes” from these injectables in a person who has taken these injections every year since early 2021?

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

The following is not medical advice. They are opinions:

Any person who has ever taken a COVID-19 “vaccine” injection — even if only one injection — of any type (modRNA, DNA viral vector, “protein subunit”, etc.) may be at risk for developing negative effects and/or outcomes induced by these “vaccines.” COVID-19 “vaccinated” persons may wish to consider having the following tests performed:

A lung scan, to investigate whether or not there are issues that can have been induced from these “vaccines”; such as, compromised alveoli or lung tissue inflammation.

A heart / cardiac scan, to investigate whether or not there are issues that can have been induced by these “vaccines”; such as, scarring of heart tissue or symptoms of preclinical myocarditis.

A D-dimer test performed, to investigate whether or not there are elevated levels of microclots in the blood, which can have been induced by these “vaccines.”

An IgG3 panel test and an IgG4 panel test performed, to investigate whether or not there are reduced levels of IgG3 cells (the “fight the enemy cells off” immune system cells), and/or elevated levels of IgG4 cells (the “tolerate but don’t fight off” immune system cells), both of which can have been induced by these “vaccines.”

Note: The above tests usually need to be ordered by a physician; or, by another licensed healthcare professional who is approved to order these types of tests.

Interested persons may wish to consider following a post-“vaccination” recovery treatment protocol, such as the one outlined here, from the Independent Medical Alliance: https://imahealth.org/protocol/i-recover-post-vaccine-treatment.

For those who are not COVID-19 “vaccinated”, there is the now-proven phenomenon of “vaccine shedding” from “vaccinated” persons onto other persons, including onto non-“vaccinated” persons. Please see: https://pierrekorymedicalmusings.com/p/newly-published-study-shows-shedding, “Newly Published Study Shows Shedding Of Covid mRNA Vaccine Products”, 9 December 2024.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

THE COVID-19 “VACCINES” — ALL OF THEM — MUST BE REMOVED FROM THE MARKET AND FROM USE IN THE UNITED STATES. NOW.

THERE MUST BE ACCOUNTABILITY, JUSTICE, AND TRUTH.

Peace, Good Energy, Respect: PAVACA

(Intellectual Property Disclaimer and Notice: The ideas and opinions in today’s offering are by PAVACA. Credit must be given to PAVACA if ideas or opinions in today’s offering are used by other blog writers, by podcasters, or in social or print media.)